Rituximab Overview
Introduction of Rituximab
Rituximab is a genetically engineered chimeric murine/human monoclonal antibody targeting CD20 antigen, which is primarily found on the surface of immune system B cells. This drug is an IgG1 kappa immunoglobulin antibody containing murine light and heavy-chain variable region sequences and human constant region sequences. Rituximab was developed by Biogen Idec and is co-promoted by Genentech, a subsidiary of Roche Group. Rituximab is used for the treatment of diseases which are characterized by having too many B cells, overactive B cells, or dysfunctional B cells as it could bind to CD20 on normal or malignant B cells. The diseases that rituximab can treat include Non–Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA) in combination with methotrexate in adult patients with moderately-to severely-active RA, Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis), and Microscopic Polyangiitis (MPA). Rituximab was approved by the U.S. Food and Drug Administration (FDA) as a single agent to treat patients with B-cell Non-Hodgkin's Lymphoma (NHL) under a brand name Rituxan in1997. One year later, the drug was approved by the European Commission and sold under the trade name MabThera. In October 2010, European Commission approved Rituxan as a maintenance treatment for advanced follicular lymphoma patients, and the US FDA approved the drug for similar indication on 28 January 2011.
Mechanism of Action of Rituximab
Rituximab is an antibody drug that targets the CD20 antigen, which was expressed in 90% of B lymphoma cells and normal B lymphoid cells, but not in hematopoietic stem cells, primary B lymphoid cells, normal blood cells and other normal tissues.
Rituximab consists of a murine variable region (Fab region) and a human constant region (Fc region). The Fab region has variable sections that define a specific target antigen, which allows the antibody to secure its binding to exclusive antigen. The Fc region is the tail end of the antibody that binds to cell surface receptors to induce sequence events including the depletion of circulating B lymphocytes by complement-dependent cell lysis, antibody-dependent cellular cytotoxicity (ADCC), as well as apoptosis, activating the immune system. When rituximab binding to CD20, the body's natural immune defenses are recruited to attack and kill the marked B-cells, leading to B-cell lysis. Stem cells do not have the CD20 antigen, and thus, healthy B-cells can regenerate after treatment.
Fig.1 Mechanism of action of Rituximab
Table 1. Clinical Projects of Rituximab*
| NCT ID | Status | Conditions | Lead Sponsor | Update Time |
| NCT03639324 | Not yet recruiting | Chronic Lymphocytic Leukemia;CLL;Relapsed CLL;Refractory Chronic Lymphocytic Leukemia;Relapsed Chronic Lymphocytic Leukemia | Virginia Commonwealth University | November 14, 2018 |
| NCT01804712 | Active, not recruiting | Prostate Cancer | Stephen Howell, M.D. | May 19, 2017 |
| NCT03689894 | Not yet recruiting | Chronic Graft-versus-host-disease | Dartmouth-Hitchcock Medical Center | November 30, 2018 |
| NCT03372837 | Recruiting | Assess the Efficacy and Safety of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed DLBCL | SymBio Pharmaceuticals | January 23, 2018 |
| NCT03072199 | Recruiting | Ischemic Heart Disease;Myocardial Infarction;Inflammation | Papworth Hospital NHS Foundation Trust | August 31, 2018 |
| NCT02474888 | Recruiting | Granulomatosis, Wegener's;Microscopic Polyangiitis | Centre Hospitalier Universitaire de Saint Etienne | September 24, 2018 |
| NCT02753062 | Recruiting | Diffuse Large B Cell Lymphoma | Asan Medical Center | April 27, 2016 |
| NCT02304354 | Recruiting | Rheumatoid Arthritis | University Hospital, Tours | October 26, 2017 |
| NCT03232307 | Not yet recruiting | Hematopoietic/Lymphoid Cancer;Mantle Cell Lymphoma | M.D. Anderson Cancer Center | October 9, 2018 |
| NCT01573533 | Active, not recruiting | Primary Focal Segmental Glomerulosclerosis | Mayo Clinic | November 6, 2018 |
| NCT03298698 | Recruiting | Idiopathic Nephrotic Syndrome;Minimal Change Disease;Focal Segmental Glomerulosclerosis | Radboud University | August 27, 2018 |
| NCT01842386 | Active, not recruiting | Anticytokine Autoantibody-Associated Diseases;Disseminated Non-Tuberculous Mycobacteria;Chronic Mucocutaneous Candidiasis;Pulmonary Alveolar Proteinosis (PAP) | National Institute of Allergy and Infectious Diseases (NIAID) | November 2, 2018 |
| NCT02898259 | Recruiting | B Cell Lymphoma;Lymphoma | Case Comprehensive Cancer Center | May 18, 2018 |
| NCT03010202 | Recruiting | Purpura, Thrombocytopenic, Idiopathic | August 24, 2018 | |
| NCT01665768 | Active, not recruiting | CD20+, B-cell Lymphomas;Mantle Cell Lymphoma;Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL);Transformed Lymphoma/DLBCL/PMBCL;Hodgkin's Disease;Gray Zone Lymphoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | July 13, 2017 |
| NCT00858117 | Active, not recruiting | Leukemia | Northwestern University | February 6, 2018 |
| NCT02433795 | Active, not recruiting | Marginal Zone B-cell Lymphoma | Seoul National University Hospital | June 21, 2018 |
| NCT03467867 | Recruiting | Chronic Lymphocytic Leukemia | Georgetown University | June 1, 2018 |
| NCT02451111 | Recruiting | Follicular Lymphoma | Swiss Group for Clinical Cancer Research | October 1, 2018 |
| NCT01554514 | Active, not recruiting | Thrombotic Thrombocytopenic Purpura | Washington University School of Medicine | November 5, 2018 |
| NCT02749292 | Recruiting | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Massachusetts General Hospital | August 21, 2018 |
| NCT00783367 | Active, not recruiting | Follicular Lymphoma;Marginal Zone B-Cell Lymphoma;MALT Lymphoma;Lymphoma of Mucosa-Associated Lymphoid Tissue;Lymphoma, Small Lymphocytic;Waldenstrom Macroglobulinemia;Mantle-Cell Lymphoma | Abramson Cancer Center of the University of Pennsylvania | January 25, 2017 |
| NCT02481297 | Active, not recruiting | Leukemia;Chronic Lymphocytic Leukemia;Lymphocytic Leukemia | M.D. Anderson Cancer Center | July 3, 2018 |
| NCT01956695 | Active, not recruiting | Lymphoma;Relapse | Institut Curie | April 6, 2018 |
| NCT02446457 | Active, not recruiting | Lymphoma | M.D. Anderson Cancer Center | November 14, 2018 |
| NCT02162771 | Active, not recruiting | Lymphoma, Follicular | Celltrion | August 28, 2017 |
| NCT03582098 | Recruiting | Chronic Lymphocytic Leukaemia | Gilead Sciences | November 7, 2018 |
| NCT02267915 | Active, not recruiting | Mantle-cell Lymphoma | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | April 25, 2018 |
| NCT02303119 | Recruiting | Follicular Lymphoma | The Lymphoma Academic Research Organisation | November 27, 2018 |
| NCT01238692 | Active, not recruiting | Diffuse Large B Cell Lymphoma | Sarit Assouline | December 6, 2016 |
| NCT03304288 | Recruiting | Immune Thrombocytopenia | Peking University People's Hospital | October 10, 2017 |
| NCT01316523 | Active, not recruiting | Non Hodgkin's Lymphoma | University of California, Davis | July 18, 2018 |
| NCT03361852 | Not yet recruiting | Follicular Lymphoma | Dana-Farber Cancer Institute | March 14, 2018 |
| NCT01429610 | Active, not recruiting | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Asan Medical Center | July 24, 2018 |
| NCT02843061 | Recruiting | B-cell Lymphoma Recurrent | Fuda Cancer Hospital, Guangzhou | July 25, 2016 |
| NCT03136497 | Recruiting | Relapsed Diffuse Large B-Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma | Hackensack Meridian Health | July 9, 2018 |
| NCT02950155 | Recruiting | Generalized Myasthenia Gravis | Fredrik Piehl | April 4, 2018 |
| NCT03267433 | Recruiting | CD20 Positive;Mantle Cell Lymphoma | ECOG-ACRIN Cancer Research Group | December 8, 2017 |
| NCT01118234 | Active, not recruiting | Chronic Lymphocytic Leukemia | Arbeitsgemeinschaft medikamentoese Tumortherapie | November 27, 2017 |
| NCT03336333 | Recruiting | Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma | BeiGene | October 19, 2018 |
| NCT01996865 | Recruiting | Lymphoma, Non-Hodgkin | Celgene | October 16, 2018 |
| NCT01307605 | Active, not recruiting | Lymphoma | Swiss Group for Clinical Cancer Research | May 8, 2018 |
| NCT03307746 | Recruiting | B Cell Lymphoma | University Hospital Southampton NHS Foundation Trust | September 7, 2018 |
| NCT02990286 | Recruiting | Lung Disease, Interstitial | University Hospital, Tours | May 8, 2017 |
| NCT02705638 | Recruiting | Immunoglobulin G Subclass 4 Related Disease;IgG4-related Disease;Autoimmune Pancreatitis;IgG4-related Sclerosing Cholangitis;Retroperitoneal Fibrosis | Mayo Clinic | February 21, 2018 |
| NCT01697267 | Active, not recruiting | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Microscopic Polyangiitis;Wegener Granulomatosis | Cambridge University Hospitals NHS Foundation Trust | July 23, 2018 |
| NCT01889069 | Active, not recruiting | Lymphoma | Hoffmann-La Roche | September 11, 2018 |
| NCT01682616 | Active, not recruiting | Small Lymphocytic Lymphoma;Chronic Lymphocytic Leukemia | AbbVie | November 20, 2018 |
| NCT03545035 | Not yet recruiting | Chronic Lymphocytic Leukemia | Gruppo Italiano Malattie EMatologiche dell'Adulto | October 15, 2018 |
| NCT03501459 | Recruiting | Nephrotic Syndrome | National University Health System, Singapore | April 18, 2018 |
| NCT03609593 | Not yet recruiting | Chronic Lymphocytic Leukemia | Nicole Lamanna | August 3, 2018 |
| NCT03700229 | Recruiting | Acquired Hemophilia A | Peking Union Medical College Hospital | November 22, 2018 |
| NCT03578198 | Not yet recruiting | CD20-positive Non-Hodgkin Lymphoma | Seoul National University Hospital | July 6, 2018 |
| NCT03571568 | Recruiting | Indolent B-Cell Non-Hodgkin Lymphoma | BioInvent International AB | October 23, 2018 |
| NCT02747043 | Recruiting | Lymphoma, Non-Hodgkin | Amgen | November 12, 2018 |
| NCT00075946 | Active, not recruiting | Lymphoma | Eastern Cooperative Oncology Group | June 22, 2015 |
| NCT01125293 | Active, not recruiting | Waldenstrom's Macroglobulinemia | Dana-Farber Cancer Institute | November 5, 2018 |
| NCT02382575 | Recruiting | Nephrotic Syndrome | Nilratan Sircar Medical College | March 29, 2018 |
| NCT02945215 | Recruiting | B-Cell Lymphoma | Innovent Biologics (Suzhou) Co. Ltd. | April 11, 2017 |
| NCT03295383 | Not yet recruiting | Severe Forms of Mucous Membrane Pemphigoid | University Hospital, Rouen | May 28, 2018 |
| NCT02427620 | Recruiting | Lymphoma | M.D. Anderson Cancer Center | October 8, 2018 |
| NCT02433522 | Active, not recruiting | ANCA-associated Vasculitides | Assistance Publique - Hôpitaux de Paris | March 2, 2018 |
| NCT02187133 | Recruiting | Lymphoma, Non-Hodgkin;Lymphoma | University of California, San Francisco | November 6, 2018 |
| NCT03003039 | Recruiting | B-Cell Lymphoma | Nanjing Yoko Biomedical Co., Ltd. | December 26, 2016 |
| NCT02007044 | Active, not recruiting | Leukemia | M.D. Anderson Cancer Center | October 22, 2018 |
| NCT03710772 | Not yet recruiting | CD20 Positive;Mantle Cell Lymphoma | M.D. Anderson Cancer Center | October 18, 2018 |
| NCT03245021 | Recruiting | Follicular Lymphoma | Dr. Eliza Hawkes | September 11, 2017 |
| NCT02682641 | Recruiting | Mantle Cell Lymphoma | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | June 27, 2018 |
| NCT03424122 | Recruiting | B-cell Lymphoma | Incyte Corporation | August 23, 2018 |
| NCT02141451 | Recruiting | Diffuse Large B Cell Non-Hodgkin Lymphoma | Masonic Cancer Center, University of Minnesota | September 26, 2018 |
| NCT01933711 | Active, not recruiting | CD20+ Aggressive Lymphoma, Mantle Cell Lymphoma | University Hospital Heidelberg | May 13, 2016 |
| NCT03623373 | Not yet recruiting | Mantle Cell Lymphoma | Washington University School of Medicine | November 15, 2018 |
| NCT03523975 | Not yet recruiting | Mantle Cell Lymphoma | University of Michigan Cancer Center | October 17, 2018 |
| NCT02752204 | Active, not recruiting | Diffuse Large B-Cell Lymphoma | University of Birmingham | May 10, 2018 |
| NCT02980042 | Recruiting | Multiple Sclerosis | University of Colorado, Denver | December 26, 2017 |
| NCT02406092 | Active, not recruiting | Non-Hodgkin Lymphoma | Hoffmann-La Roche | November 1, 2018 |
| NCT01473628 | Recruiting | Lymphoma | M.D. Anderson Cancer Center | May 7, 2018 |
| NCT03703167 | Not yet recruiting | Primary Central Nervous System Lymphoma (PCNSL);Secondary Central Nervous System Lymphoma (SCNSL) | Memorial Sloan Kettering Cancer Center | October 11, 2018 |
| NCT03315923 | Not yet recruiting | Progressive Multiple Sclerosis | Isfahan University of Medical Sciences | October 23, 2017 |
| NCT00877214 | Active, not recruiting | Follicular Lymphomas;Immunocytomas;Marginal Zone Lymphomas;Mantle-Cell Lymphomas;Lymphocytic Lymphoma;Non-Hodgkin's Lymphoma | Jurgen Barth | January 12, 2018 |
| NCT02746744 | Recruiting | Multiple Sclerosis, Relapsing-Remitting | Anders Svenningsson | October 27, 2017 |
| NCT00788684 | Active, not recruiting | CD20-Positive Lymphoid Malignancies;Chronic Lymphoid Leukemia;Hematological Malignancies;Non-Hodgkin's Lymphoma | AbbVie (prior sponsor, Abbott) | October 3, 2018 |
| NCT00492050 | Active, not recruiting | Waldenstrom's Macroglobulinemia | M.D. Anderson Cancer Center | May 18, 2018 |
| NCT02807103 | Recruiting | Eosinophilic Granulomatosis With Polyangiitis (EGPA) | Assistance Publique - Hôpitaux de Paris | March 19, 2018 |
| NCT02383589 | Active, not recruiting | Pemphigus Vulgaris | Hoffmann-La Roche | September 11, 2018 |
| NCT03018535 | Recruiting | Glomerulonephritis, Membranous | Azienda Ospedaliera Spedali Civili di Brescia | January 12, 2017 |
| NCT02394119 | Recruiting | Nephrotic Syndrome | Istituto Giannina Gaslini | May 4, 2017 |
| NCT02086175 | Recruiting | Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas | Dana-Farber Cancer Institute | May 9, 2018 |
| NCT01491841 | Active, not recruiting | Non-Hodgkin's Lymphoma | Anne Beaven, MD | October 3, 2016 |
| NCT02953509 | Recruiting | Lymphoma, Non-Hodgkin;Lymphoma, Large B-Cell, Diffuse;Indolent Lymphoma | Forty Seven, Inc. | August 1, 2018 |
| NCT03194815 | Recruiting | Psychosis;Autoimmune Encephalitis | University of Cambridge | February 19, 2018 |
| NCT03688451 | Recruiting | Non Hodgkin Lymphoma | Tahir Latif | September 28, 2018 |
| NCT03443570 | Not yet recruiting | Immune Thrombocytopenia;Purpura, Thrombocytopenic, Idiopathic | Shandong University | February 23, 2018 |
| NCT02636322 | Recruiting | Lymphoma | M.D. Anderson Cancer Center | November 14, 2018 |
| NCT01199575 | Active, not recruiting | Chronic Lymphocytic Leukemia;CLL | University of California, San Diego | October 23, 2018 |
| NCT02747732 | Recruiting | Diffuse Large B Cell Lymphoma;Primary Mediastinal (Thymic) Large B-cell Lymphoma;Transformed Indolent Lymphoma;Recurrent Disease;Refractory Cancer | Meirav Kedmi MD | March 8, 2017 |
| NCT02853370 | Active, not recruiting | Marginal Zone B-cell Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | February 28, 2018 |
| NCT01307267 | Active, not recruiting | Lymphoma, Non-Hodgkin;Lymphoma, Follicular;Lymphoma, Large B-Cell, Diffuse;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Carcinoma, Squamous Cell of Head and Neck;Malignant Melanoma | Pfizer | October 12, 2018 |
| NCT03189836 | Recruiting | Lymphoma | Unum Therapeutics Inc. | March 20, 2018 |
| NCT03161457 | Recruiting | Rheumatoid Arthritis;Arthritis, Rheumatoid | JHL Biotech, Inc. | July 13, 2018 |
| NCT01446133 | Active, not recruiting | Leukemia;Lymphoma | M.D. Anderson Cancer Center | February 12, 2018 |
| NCT02367040 | Recruiting | Lymphoma,Non-Hodgkin | Bayer | November 12, 2018 |
| NCT02532257 | Active, not recruiting | Lymphoma;Follicular Lymphoma (FL) | M.D. Anderson Cancer Center | June 25, 2018 |
| NCT01429025 | Active, not recruiting | Refractory/Relapsed Indolent Non-Hodgkin Lymphoma | Alliance for Clinical Trials in Oncology | August 9, 2017 |
| NCT02232386 | Active, not recruiting | Chronic Lymphocyte Leukemia;Adult Patients | Gruppo Italiano Malattie EMatologiche dell'Adulto | November 6, 2017 |
| NCT02556866 | Active, not recruiting | Cryoglobulinemia;Systemic Vasculitis | Assistance Publique - Hôpitaux de Paris | November 6, 2017 |
| NCT01650701 | Active, not recruiting | Follicular Lymphoma | The Lymphoma Academic Research Organisation | April 12, 2018 |
| NCT00848328 | Active, not recruiting | Lymphoma | University of California, Davis | March 2, 2018 |
| NCT03630042 | Not yet recruiting | Waldenstrom Macroglobulinemia | University College, London | August 14, 2018 |
| NCT02809053 | Recruiting | Lymphoma, Follicular | Archigen Biotech Limited | March 12, 2018 |
| NCT02384954 | Recruiting | Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma | Altor BioScience | May 8, 2018 |
| NCT02160015 | Active, not recruiting | Ann Arbor Stage III Small Lymphocytic Lymphoma;Ann Arbor Stage IV Small Lymphocytic Lymphoma;Recurrent Chronic Lymphocytic Leukemia;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic Leukemia;Refractory Small Lymphocytic Lymphoma;Stage III Chronic Lymphocytic Leukemia;Stage IV Chronic Lymphocytic Leukemia | National Cancer Institute (NCI) | November 21, 2018 |
| NCT03061838 | Recruiting | Rheumatoid Arthritis | Biointegrator LLC | February 23, 2017 |
| NCT00412594 | Recruiting | Leukemia | M.D. Anderson Cancer Center | December 8, 2017 |
| NCT01695941 | Active, not recruiting | Recurrent B-Cell Non-Hodgkin Lymphoma;Recurrent Mantle Cell Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Mantle Cell Lymphoma | National Cancer Institute (NCI) | October 22, 2018 |
| NCT02972840 | Recruiting | Lymphoma, Mantle Cell | Acerta Pharma BV | February 20, 2018 |
| NCT01939327 | Recruiting | Non-Hodgkin Lymphoma | Institut Paoli-Calmettes | October 26, 2017 |
| NCT00923013 | Recruiting | Hairy Cell Leukemia | National Cancer Institute (NCI) | September 25, 2018 |
| NCT02966717 | Active, not recruiting | Renal Insufficiency, Chronic;Nephrotic Syndrome | Zhujiang Hospital | November 22, 2016 |
| NCT03558750 | Recruiting | Recurrent Central Nervous System Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Refractory Central Nervous System Lymphoma;Refractory Diffuse Large B-Cell Lymphoma | Vanderbilt-Ingram Cancer Center | June 18, 2018 |
| NCT03352765 | Recruiting | Lymphoma | Memorial Sloan Kettering Cancer Center | August 13, 2018 |
| NCT03670901 | Not yet recruiting | Diffuse Large B-Cell Lymphoma | JHL Biotech, Inc. | September 14, 2018 |
| NCT03154385 | Recruiting | Immune Thrombocytopenia | Assistance Publique - Hôpitaux de Paris | May 16, 2017 |
| NCT01938001 | Active, not recruiting | Lymphoma, Non-Hodgkin | Celgene | October 30, 2018 |
| NCT02914938 | Recruiting | Chronic Lymphocytic Leukemia (CLL);Small Lymphocytic Lymphoma (SLL);Follicular Lymphoma (FL);Marginal Zone B Cell Lymphoma;Diffuse Large B-cell Lymphoma (DLBCL);High Grade Non-Hodgkin's Lymphoma | MEI Pharma, Inc. | June 28, 2018 |
| NCT01569295 | Active, not recruiting | Chronic Lymphocytic Leukemia | Gilead Sciences | November 6, 2018 |
| NCT01542918 | Active, not recruiting | Recurrent/Refractory CNS;Intraocular Lymphoma | University of California, San Francisco | January 29, 2018 |
| NCT02371148 | Active, not recruiting | Waldenstrom's Macroglobulinemia | Fondazione Italiana Linfomi ONLUS | November 26, 2018 |
| NCT03164473 | Recruiting | Eosinophilic Granulomatosis With Polyangiitis | Assistance Publique - Hôpitaux de Paris | March 19, 2018 |
| NCT02165397 | Active, not recruiting | Waldenström's Macroglobulinemia | Pharmacyclics LLC. | May 8, 2018 |
| NCT01829568 | Active, not recruiting | Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma;Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma;Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma;Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma;Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma;Ann Arbor Stage III Grade 1 Follicular Lymphoma;Ann Arbor Stage III Grade 2 Follicular Lymphoma;Ann Arbor Stage III Grade 3 Follicular Lymphoma;Ann Arbor Stage IV Grade 1 Follicular Lymphoma;Ann Arbor Stage IV Grade 2 Follicular Lymphoma;Ann Arbor Stage IV Grade 3 Follicular Lymphoma;CD20 Positive | National Cancer Institute (NCI) | July 17, 2018 |
| NCT02660710 | Recruiting | Diffuse Large B-cell Lymphoma;HIV | UNC Lineberger Comprehensive Cancer Center | May 24, 2018 |
| NCT01516580 | Active, not recruiting | B-cell Non Hodgkin Lymphoma;Mature B-cell Leukemia Burkitt-type | Gustave Roussy, Cancer Campus, Grand Paris | June 14, 2017 |
| NCT02763319 | Recruiting | Diffuse Large B-cell Lymphoma | MorphoSys AG | September 5, 2018 |
| NCT02757196 | Not yet recruiting | Immune Thrombocytopenia | Peking University People's Hospital | May 13, 2016 |
| NCT03719131 | Not yet recruiting | Cutaneous Melanoma, Stage III;Cutaneous Melanoma, Stage IV;Stage III Melanoma;Stage IIIA Skin Melanoma;Stage IIIB Skin Melanoma;Stage IIIC Skin Melanoma;Stage IV Skin Melanoma;Unresectable Melanoma; | Emory University | October 25, 2018 |
| NCT02042391 | Recruiting | Posttransplant Lymphoproliferative Disorder | Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH | July 24, 2018 |
| NCT03401853 | Recruiting | Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma | University of Washington | November 12, 2018 |
| NCT02867553 | Active, not recruiting | Indolent Cutaneous B Cell Lymphomas | CHU de Reims | September 7, 2016 |
| NCT02390869 | Recruiting | Lymphoma, Follicular | Fondazione Italiana Linfomi ONLUS | June 20, 2018 |
| NCT02446236 | Recruiting | Mantle Cell Lymphoma | Hackensack Meridian Health | July 6, 2018 |
| NCT00383994 | Active, not recruiting | Lymphoma;Leukemia;Transplantation, Stem Cell;Lymphoid Malignancies;Disorder Related to Transplantation | M.D. Anderson Cancer Center | November 30, 2018 |
| NCT03269552 | Recruiting | Marginal Zone Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Waldenstrom Macroglobulinemia;Refractory Marginal Zone Lymphoma;Refractory Waldenstrom Macroglobulinemia;Waldenstrom Macroglobulinemia | University of Washington | February 7, 2018 |
| NCT02005471 | Active, not recruiting | Chronic Lymphocytic Leukemia | Hoffmann-La Roche | October 1, 2018 |
| NCT01234766 | Active, not recruiting | Lymphoma, Follicular | Dartmouth-Hitchcock Medical Center | September 18, 2018 |
| NCT01472562 | Active, not recruiting | Mantle Cell Lymphoma | Weill Medical College of Cornell University | March 27, 2018 |
| NCT01059786 | Recruiting | Hairy Cell Leukemia | National Cancer Institute (NCI) | October 25, 2018 |
| NCT00918723 | Active, not recruiting | Chronic Lymphocytic Leukemia;Stage I Chronic Lymphocytic Leukemia;Stage I Small Lymphocytic Lymphoma;Stage II Chronic Lymphocytic Leukemia;Stage II Small Lymphocytic Lymphoma;Stage III Chronic Lymphocytic Leukemia;Stage III Small Lymphocytic Lymphoma;Stage IV Chronic Lymphocytic Leukemia;Stage IV Small Lymphocytic Lymphoma | Fred Hutchinson Cancer Research Center | February 8, 2018 |
| NCT03384277 | Recruiting | Acquired Hemophilia A | Zhang Lei | June 21, 2018 |
| NCT01754857 | Recruiting | Lymphoid Leukemia;Small Lymphocytic Lymphoma;Lymphoma, Non-Hodgkin | University of Wisconsin, Madison | June 28, 2018 |
| NCT01808911 | Recruiting | Acquired Haemophilia | University Hospital, Rouen | May 28, 2018 |
| NCT03670888 | Not yet recruiting | B Cell Lymphoma | JHL Biotech, Inc. | September 14, 2018 |
| NCT01880567 | Recruiting | CCND1 Positive;CCND2 Positive;CCND3 Positive;CD20 Positive;Mantle Cell Lymphoma;Recurrent Mantle Cell Lymphoma;Refractory Mantle Cell Lymphoma | M.D. Anderson Cancer Center | September 14, 2018 |
| NCT02128061 | Active, not recruiting | Diffuse Large B Cell Lymphoma | The Lymphoma Academic Research Organisation | December 11, 2017 |
| NCT01808599 | Active, not recruiting | MALT Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | August 27, 2018 |
| NCT01476787 | Active, not recruiting | Follicular Lymphoma | Celgene | March 23, 2018 |
| NCT00980395 | Active, not recruiting | Lymphoma;Mantle Cell Lymphoma;Indolent Lymphoma;SLL | University of Arizona | April 25, 2018 |
| NCT01180036 | Active, not recruiting | Idiopathic Membranous Nephropathy | Mayo Clinic | February 23, 2018 |
| NCT03636503 | Recruiting | Follicular Lymphoma | Dana-Farber Cancer Institute | November 6, 2018 |
| NCT02728531 | Recruiting | Mantle Cell Lymphoma | Washington University School of Medicine | September 7, 2018 |
| NCT02049541 | Active, not recruiting | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Nodal Marginal Zone B-cell Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Splenic Marginal Zone Lymphoma;Waldenström Macroglobulinemia | Kami Maddocks | September 12, 2018 |
| NCT00667329 | Active, not recruiting | Lymphoma | M.D. Anderson Cancer Center | April 24, 2018 |
| NCT03697512 | Not yet recruiting | Marginal Zone Lymphoma;Nodal Marginal Zone Lymphoma;Splenic Marginal Zone Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | October 5, 2018 |
| NCT01594229 | Active, not recruiting | Non-Hodgkin's Lymphoma | AbbVie | October 11, 2018 |
| NCT01095172 | Recruiting | Function of Renal Transplant | Guy's and St Thomas' NHS Foundation Trust | August 19, 2016 |
| NCT01381692 | Active, not recruiting | Cognitive Side Effects of Cancer Therapy;Fatigue;Neurotoxicity Syndrome;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Small Lymphocytic Lymphoma;Therapy-Related Toxicity;Waldenstrom Macroglobulinemia; | National Cancer Institute (NCI) | May 25, 2018 |
| NCT02423837 | Recruiting | Follicular Lymphoma | National Research Center for Hematology, Russia | April 22, 2015 |
| NCT03180723 | Not yet recruiting | Membranoproliferative Glomerulonephritis | Assiut University | June 16, 2017 |
| NCT02320292 | Recruiting | Stage I Grade 1 Follicular Lymphoma;Stage I Grade 2 Follicular Lymphoma;Stage II Grade 1 Contiguous Follicular Lymphoma;Stage II Grade 1 Non-Contiguous Follicular Lymphoma;Stage II Grade 2 Contiguous Follicular Lymphoma;Stage II Grade 2 Non-Contiguous Follicular Lymphoma;Stage III Grade 1 Follicular Lymphoma;Stage III Grade 2 Follicular Lymphoma;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma; | Mayo Clinic | February 6, 2018 |
| NCT01862926 | Recruiting | Interstitial Lung Disease;Scleroderma;Mixed Connective Tissue Disease;Idiopathic Inflammatory Myositis; | Royal Brompton & Harefield NHS Foundation Trust | June 8, 2017 |
| NCT00695786 | Active, not recruiting | Ann Arbor Stage III Grade 1 Follicular Lymphoma;Ann Arbor Stage III Grade 2 Follicular Lymphoma;Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma;Ann Arbor Stage III Marginal Zone Lymphoma;Ann Arbor Stage III Small Lymphocytic Lymphoma;Ann Arbor Stage IV Grade 1 Follicular Lymphoma;Ann Arbor Stage IV Grade 2 Follicular Lymphoma;Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma;Ann Arbor Stage IV Marginal Zone Lymphoma;Ann Arbor Stage IV Small Lymphocytic Lymphoma; | M.D. Anderson Cancer Center | September 18, 2018 |
| NCT02631538 | Active, not recruiting | Sjogren's Syndrome | GlaxoSmithKline | September 10, 2018 |
| NCT01702961 | Active, not recruiting | Lymphoma;Hodgkin's Disease | Baylor College of Medicine | June 29, 2018 |
| NCT03295240 | Recruiting | Mantle Cell Lymphoma;Lymphoma | Memorial Sloan Kettering Cancer Center | November 9, 2018 |
| NCT01516567 | Active, not recruiting | Primary Mediastinal Large B Cell Lymphoma | Gustave Roussy, Cancer Campus, Grand Paris | August 2, 2017 |
| NCT03505944 | Not yet recruiting | Relapsed Non Hodgkin Lymphoma | Nordic Lymphoma Group | April 23, 2018 |
| NCT02844322 | Recruiting | Waldenström Macroglobulinemia | Institute of Hematology & Blood Diseases Hospital | July 26, 2016 |
| NCT01267812 | Active, not recruiting | Contiguous Stage II Mantle Cell Lymphoma;Noncontiguous Stage II Mantle Cell Lymphoma;Recurrent Mantle Cell Lymphoma;Stage I Mantle Cell Lymphoma;Stage III Mantle Cell Lymphoma;Stage IV Mantle Cell Lymphoma; | City of Hope Medical Center | September 6, 2018 |
| NCT03455517 | Not yet recruiting | Chronic Myeloid Leukemia | Gruppo Italiano Malattie EMatologiche dell'Adulto | October 22, 2018 |
| NCT02316691 | Recruiting | Thyroid Eye Disease | University of Pittsburgh | June 7, 2018 |
| NCT01865110 | Recruiting | Mantle Cell Lymphoma | The Lymphoma Academic Research Organisation | March 7, 2018 |
| NCT03255096 | Recruiting | Diffuse Large B-cell Lymphoma (DLBCL) | Hoffmann-La Roche | November 26, 2018 |
| NCT00596154 | Active, not recruiting | CNS Lymphoma;CNS Brain Cancer;Non-Hodgkin's Lymphoma | Memorial Sloan Kettering Cancer Center | October 16, 2018 |
| NCT02632396 | Recruiting | Mantle Cell Lymphoma | Emory University | March 23, 2018 |
| NCT01445535 | Active, not recruiting | T-Cell Peripheral Lymphoma;Gamma Delta Hepatosplenic T-Cell Lymphoma;Subcutaneous Panniculitis-Like T-Cell Lymphoma;NK T-Cell Lymphoma | National Cancer Institute (NCI) | September 27, 2018 |
| NCT02564744 | Recruiting | Diffuse Large B-Cell Lymphoma;B-cell Non-Hodgkin's Lymphoma | Debiopharm International SA | November 26, 2018 |
| NCT03289182 | Recruiting | Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | Hoffmann-La Roche | October 3, 2018 |
| NCT00112931 | Active, not recruiting | Lymphoma | University College, London | October 26, 2017 |
| NCT02257242 | Recruiting | Lymphoma, Non-Hodgkin;Lymphoma, Follicular;Lymphoma, Mantle-Cell;Lymphoma, Small-Cell;Waldenstrom Macroglobulinemia;Lymphoma, B-Cell, Marginal Zone; | Adam Olszewski | September 26, 2018 |
| NCT00392990 | Active, not recruiting | Lymphoma | Northwestern University | March 16, 2017 |
| NCT01427114 | Active, not recruiting | Lymphoma | Konkuk University Medical Center | August 18, 2017 |
| NCT01165112 | Active, not recruiting | Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Hodgkin Lymphoma | University of Washington | May 25, 2017 |
| NCT03135262 | Recruiting | Follicular Lymphoma;Lymphoma, Large B-Cell, Diffuse | Hoffmann-La Roche | November 12, 2018 |
| NCT02460276 | Recruiting | Relapsed/Refractory Mantle Cell Lymphoma | Lund University Hospital | August 27, 2018 |
| NCT01086540 | Active, not recruiting | Systemic Sclerosis-Associated PAH | National Institute of Allergy and Infectious Diseases (NIAID) | May 14, 2018 |
| NCT01862445 | Active, not recruiting | CLL;B-cell;Small Lymphocytic Lymphoma;Untreated B-CLL;Elderly Patients | Gruppo Italiano Malattie EMatologiche dell'Adulto | March 22, 2018 |
| NCT01661881 | Active, not recruiting | Mantle Cell Lymphoma | Dana-Farber Cancer Institute | September 6, 2018 |
| NCT02933320 | Recruiting | B-cell Lymphoma;Chronic Lymphocytic Leukaemia;Waldenström Macroglobulinaemia | Cancer Research UK | February 2, 2018 |
| NCT01136395 | Active, not recruiting | Kidney Transplantation;Rituximab;Living Donors;Immunology;Virus | University of Giessen | November 21, 2017 |
| NCT02819726 | Active, not recruiting | Rheumatoid Arthritis | Archigen Biotech Limited | December 27, 2017 |
| NCT02900976 | Recruiting | August 7, 2018 | ||
| NCT02077166 | Active, not recruiting | Relapsed Diffuse Large B-Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma | Pharmacyclics LLC. | October 15, 2018 |
| NCT03422523 | Recruiting | Diffuse Large B Cell Lymphoma;Relapsed Diffuse Large B-Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma | University Hospital Southampton NHS Foundation Trust | July 19, 2018 |
| NCT03054259 | Recruiting | Systemic Lupus Erythematosus Arthritis | University of Leeds | May 30, 2017 |
| NCT02624986 | Active, not recruiting | Non-Hodgkin's Lymphoma | Hoffmann-La Roche | October 23, 2018 |
| NCT01859819 | Recruiting | Diffuse Large Cell Lymphoma;Burkitt's Lymphoma;High Grade B-cell Lymphoma | New York Medical College | March 29, 2018 |
| NCT02180711 | Recruiting | Follicular Lymphoma (FL) | Acerta Pharma BV | March 5, 2018 |
| NCT03474744 | Not yet recruiting | Marginal Zone Lymphoma | Christian Buske | March 23, 2018 |
| NCT02970318 | Recruiting | Chronic Lymphocytic Leukemia | Acerta Pharma BV | May 25, 2017 |
| NCT01030900 | Active, not recruiting | Hodgkin Lymphoma;Diffuse Large B-Cell Lymphoma | National Cancer Institute (NCI) | November 21, 2018 |
| NCT02266888 | Active, not recruiting | Lung Transplant | National Institute of Allergy and Infectious Diseases (NIAID) | November 1, 2018 |
| NCT01691898 | Active, not recruiting | Follicular Lymphoma;Diffuse Large B-Cell Lymphoma | Genentech, Inc. | October 29, 2018 |
| NCT01955187 | Recruiting | MEMBRANOUS NEPHROPATHY | Hospital Universitario 12 de Octubre | August 19, 2016 |
| NCT00210353 | Active, not recruiting | Lymphoma, Mucosa-Associated Lymphoid Tissue | International Extranodal Lymphoma Study Group (IELSG) | July 27, 2016 |
| NCT01723839 | Active, not recruiting | Chronic Lymphocytic Leukemia (CLL) | Hackensack Meridian Health | August 10, 2017 |
| NCT03332888 | Not yet recruiting | Heart Failure With Reduced Ejection Fraction | Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud | November 16, 2018 |
| NCT02400437 | Active, not recruiting | Waldenstrom's Macroglobulinemia | Dana-Farber Cancer Institute | October 29, 2018 |
| NCT02378298 | Recruiting | Ophthalmopathy, Thyroid-Associated | Göteborg University | August 21, 2018 |
| NCT02260934 | Active, not recruiting | Lupus Nephritis | National Institute of Allergy and Infectious Diseases (NIAID) | June 14, 2018 |
| NCT03069703 | Recruiting | Invasive Pneumococcal Infection | Assistance Publique - Hôpitaux de Paris | March 19, 2018 |
| NCT03560011 | Not yet recruiting | Steroid-Dependent Nephrotic Syndrome | Assistance Publique - Hôpitaux de Paris | June 18, 2018 |
| NCT01959698 | Recruiting | CD20 Positive;Recurrent Diffuse Large B-Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Stage I Diffuse Large B-Cell Lymphoma;Stage II Diffuse Large B-Cell Lymphoma;Stage III Diffuse Large B-Cell Lymphoma;Stage IV Diffuse Large B-Cell Lymphoma; | Roswell Park Cancer Institute | March 29, 2018 |
| NCT01592981 | Active, not recruiting | Waldenstrom's Macroglobulinaemia | University College, London | November 17, 2017 |
| NCT01332968 | Active, not recruiting | Non-Hodgkin's Lymphoma | Hoffmann-La Roche | September 24, 2018 |
| NCT02957019 | Recruiting | Diffuse Large B-cell Lymphoma (DLBCL) | Philogen S.p.A. | May 25, 2018 |
| NCT02491398 | Active, not recruiting | Chronic Lymphocytic Leukemia | Gruppo Italiano Malattie EMatologiche dell'Adulto | August 6, 2018 |
| NCT03259529 | Recruiting | Diffuse Large B Cell Lymphoma | St. Petersburg State Pavlov Medical University | September 6, 2018 |
| NCT01856192 | Active, not recruiting | Ann Arbor Stage II DiffuseAnn Arbor Stage IV Diffuse Large B-Cell Lymphoma； Large B-Cell Lymphoma；Ann Arbor Stage III Diffuse Large B-Cell Lymphoma；CD20 Positive | National Cancer Institute (NCI) | September 13, 2018 |
| NCT00599170 | Active, not recruiting | Diffuse, Large B-Cell, Lymphoma | University of Southern California | April 2, 2018 |
| NCT02198248 | Recruiting | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis；Microscopic Polyangiitis；Wegener Granulomatosis | Chiba University | January 25, 2018 |
| NCT02031419 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse | Celgene | September 11, 2018 |
| NCT02453087 | Active, not recruiting | Non-Hodgkin's Lymphoma | Hoffmann-La Roche | September 14, 2018 |
| NCT01125176 | Active, not recruiting | Chronic Lymphocytic Leukemia | Weill Medical College of Cornell University | September 18, 2018 |
| NCT02048813 | Active, not recruiting | Anemia;Chronic Lymphocytic Leukemia;Fatigue;Fever, Sweat, and Hot Flashes;Hepatomegaly;Lymphadenopathy;Lymphocytosis;Small Lymphocytic Lymphoma;Splenomegaly;Thrombocytopenia;Weight Change; | National Cancer Institute (NCI) | November 2, 2018 |
| NCT02501473 | Recruiting | Follicular Low Grade Non-Hodgkin's Lymphoma | Immune Design | October 19, 2018 |
| NCT03003546 | Not yet recruiting | Aggressive Non-Hodgkin Lymphoma;CD20 Positive;Recurrent B-Cell Non-Hodgkin Lymphoma;Recurrent Small Lymphocytic Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Small Lymphocytic Lymphoma; | Mayo Clinic | April 18, 2018 |
| NCT03520920 | Recruiting | Marginal Zone Lymphoma;Follicular Lymphoma;Diffuse Large B-Cell Lymphoma | BeiGene | May 10, 2018 |
| NCT03211065 | Active, not recruiting | Secondary Immune Deficiency | Rochester General Hospital | September 19, 2018 |
| NCT01886872 | Active, not recruiting | CD19 Positive;CD20 Positive;CD5 Positive;Stage I Chronic Lymphocytic Leukemia;Stage II Chronic Lymphocytic Leukemia;Stage III Chronic Lymphocytic Leukemia;Stage IV Chronic Lymphocytic Leukemia; | National Cancer Institute (NCI) | November 2, 2018 |
| NCT01611090 | Active, not recruiting | Chronic Lymphocytic Leukemia；Small Lymphocytic Lymphoma | Janssen Research & Development, LLC | November 16, 2018 |
| NCT03620903 | Not yet recruiting | Waldenstrom Macroglobulinemia | Christian Buske | August 10, 2018 |
| NCT01044745 | Active, not recruiting | Accelerated Phase Chronic Myelogenous Leukemia;Adult Acute Lymphoblastic Leukemia in Remission;Adult Acute Myeloid Leukemia in Remission;Adult Nasal Type Extranodal NK/T-cell Lymphoma;Blastic Phase Chronic Myelogenous Leukemia;Contiguous Stage II Adult Burkitt Lymphoma;Contiguous Stage II Adult Diffuse Large Cell Lymphoma;Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma;Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma;Contiguous Stage II Adult Lymphoblastic Lymphoma;Contiguous Stage II Grade 1 Follicular Lymphoma;Contiguous Stage II Grade 2 Follicular Lymphoma;Contiguous Stage II Grade 3 Follicular Lymphoma;Contiguous Stage II Mantle Cell Lymphoma;Contiguous Stage II Marginal Zone Lymphoma;Contiguous Stage II Small Lymphocytic Lymphoma;de Novo Myelodysplastic Syndromes;Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Graft Versus Host Disease;Nodal Marginal Zone B-cell Lymphoma;Noncontiguous Stage II Adult Burkitt Lymphoma;Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;Noncontiguous Stage II Adult Lymphoblastic Lymphoma;Noncontiguous Stage II Grade 1 Follicular Lymphoma;Noncontiguous Stage II Grade 2 Follicular Lymphoma;Noncontiguous Stage II Grade 3 Follicular Lymphoma;Noncontiguous Stage II Mantle Cell Lymphoma;Noncontiguous Stage II Marginal Zone Lymphoma;Noncontiguous Stage II Small Lymphocytic Lymphoma;Previously Treated Myelodysplastic Syndromes;Recurrent Adult Acute Lymphoblastic Leukemia;Recurrent Adult Acute Myeloid Leukemia;Recurrent Adult Burkitt Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Diffuse Mixed Cell Lymphoma;Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;Recurrent Adult Grade III Lymphomatoid Granulomatosis;Recurrent Adult Immunoblastic Large Cell Lymphoma;Recurrent Adult Lymphoblastic Lymphoma;Recurrent Adult T-cell Leukemia/Lymphoma;Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Mycosis Fungoides/Sezary Syndrome;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic Leukemia;Relapsing Chronic Myelogenous Leukemia;Secondary Myelodysplastic Syndromes;Splenic Marginal Zone Lymphoma;Stage I Adult Burkitt Lymphoma;Stage I Adult Diffuse Large Cell Lymphoma;Stage I Adult Diffuse Mixed Cell Lymphoma;Stage I Adult Diffuse Small Cleaved Cell Lymphoma;Stage I Adult Immunoblastic Large Cell Lymphoma;Stage I Adult Lymphoblastic Lymphoma;Stage I Adult T-cell Leukemia/Lymphoma;Stage I Chronic Lymphocytic Leukemia;Stage I Cutaneous T-cell Non-Hodgkin Lymphoma;Stage I Grade 1 Follicular Lymphoma;Stage I Grade 2 Follicular Lymphoma;Stage I Grade 3 Follicular LymphomaStage I Mantle Cell Lymphoma;Stage I Marginal Zone Lymphoma;Stage I Mycosis Fungoides/Sezary Syndrome;Stage I Small Lymphocytic Lymphoma;Stage II Adult T-cell Leukemia/Lymphoma;Stage II Chronic Lymphocytic Leukemia;Stage II Cutaneous T-cell Non-Hodgkin Lymphoma;Stage II Mycosis Fungoides/Sezary Syndrome;Stage III Adult Burkitt Lymphoma;Stage III Adult Diffuse Large Cell Lymphoma;Stage III Adult Diffuse Mixed Cell Lymphoma;Stage III Adult Diffuse Small Cleaved Cell Lymphoma;Stage III Adult Immunoblastic Large Cell Lymphoma;Stage III Adult Lymphoblastic Lymphoma;Stage III Adult T-cell Leukemia/Lymphoma;Stage III Chronic Lymphocytic Leukemia;Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;Stage III Grade 1 Follicular Lymphoma;Stage III Grade 2 Follicular Lymphoma;Stage III Grade 3 Follicular Lymphoma;Stage III Mantle Cell Lymphoma;Stage III Marginal Zone Lymphoma;Stage III Mycosis Fungoides/Sezary Syndrome;Stage III Small Lymphocytic Lymphoma;Stage IV Adult Burkitt Lymphoma;Stage IV Adult Diffuse Large Cell Lymphoma;Stage IV Adult Diffuse Mixed Cell Lymphoma;Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;Stage IV Adult Immunoblastic Large Cell Lymphoma;Stage IV Adult Lymphoblastic Lymphoma;Stage IV Adult T-cell Leukemia/Lymphoma;Stage IV Chronic Lymphocytic Leukemia;Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma;Stage IV Grade 3 Follicular Lymphoma;Stage IV Mantle Cell Lymphoma;Stage IV Marginal Zone Lymphoma;Stage IV Mycosis Fungoides/Sezary Syndrome;Stage IV Small Lymphocytic Lymphoma;Untreated Adult Acute Lymphoblastic Leukemia;Untreated Adult Acute Myeloid Leukemia;Waldenström Macroglobulinemia; | University of Nebraska | October 2, 2017 |
| NCT00880815 | Active, not recruiting | CD20 Positive;Chronic Lymphocytic Leukemia;Follicular Lymphoma;Mantle Cell Lymphoma;Marginal Zone Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;T-Cell Non-Hodgkin Lymphoma; | M.D. Anderson Cancer Center | September 20, 2018 |
| NCT01671904 | Active, not recruiting | Chronic Lymphocytic Leukemia | Genentech, Inc. | August 10, 2018 |
| NCT03697356 | Not yet recruiting | Waldenström's Macroglobulinemia | Kosin University Gospel Hospital | October 9, 2018 |
| NCT01478542 | Recruiting | CD20+ Aggressive B-Cell Lymphoma | University Hospital, Saarland | July 16, 2018 |
| NCT02947347 | Recruiting | Treatment Naive Follicular Lymphoma | Pharmacyclics LLC. | October 11, 2018 |
| NCT02260804 | Recruiting | Follicular Lymphoma | Celltrion | June 6, 2017 |
| NCT00001337 | Recruiting | Diffuse Large B-Cell Lymphoma (DLBCL);Primary Mediastinal Large B-cell Lymphoma;Burkitt Lymphoma;Anaplastic Large-Cell Lymphoma;Gray Zone Lymphoma; | National Cancer Institute (NCI) | November 21, 2018 |
| NCT01439750 | Active, not recruiting | Mantle Cell Lymphoma | Milton S. Hershey Medical Center | August 7, 2017 |
| NCT02971982 | Recruiting | Treatment | The First Affiliated Hospital of Soochow University | November 23, 2016 |
| NCT02955823 | Recruiting | Diffuse Large B-cells Non-Hodgkin Lymphoma | Fondazione Italiana Linfomi ONLUS | April 25, 2018 |
| NCT00770224 | Active, not recruiting | Lymphoma | Southwest Oncology Group | November 15, 2018 |
| NCT02611323 | Recruiting | Non-Hodgkin's Lymphoma | Hoffmann-La Roche | November 30, 2018 |
| NCT02284984 | Recruiting | Lupus Erythematosus, Systemic | Leiden University Medical Center | August 23, 2017 |
| NCT03129828 | Recruiting | Diffuse Large B Cell Lymphoma | Prof. Dr. Clemens Schmitt | July 18, 2018 |
| NCT02257567 | Recruiting | Lymphoma | Hoffmann-La Roche | November 16, 2018 |
| NCT00104858 | Active, not recruiting | Chronic Lymphocytic Leukemia;Prolymphocytic Leukemia;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic Leukemia;Stage III Chronic Lymphocytic Leukemia;Stage III Small Lymphocytic Lymphoma;Stage IV Chronic Lymphocytic Leukemia;Stage IV Small Lymphocytic Lymphoma;T-Cell Large Granular Lymphocyte Leukemia; | Fred Hutchinson Cancer Research Center | March 27, 2018 |
| NCT00977977 | Recruiting | Nephrotic Syndrome;Proteinuria;Autoimmune Disease;Glomerular Disease;Membranous Glomerulonephritis; | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | August 9, 2018 |
| NCT02339922 | Recruiting | Chronic Lymphocytic Leukemia;Follicular Lymphoma;Lymphoplasmacytic Lymphoma;Mantle Cell Lymphoma;Marginal Zone Lymphoma;Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;Small Lymphocytic Lymphoma;Waldenstrom Macroglobulinemia; | University of Washington | June 18, 2018 |
| NCT00290511 | Active, not recruiting | Lymphoma | M.D. Anderson Cancer Center | October 3, 2018 |
| NCT00293475 | Recruiting | Central Nervous System Lymphoma | OHSU Knight Cancer Institute | May 3, 2018 |
| NCT02734771 | Recruiting | Diffuse Large B-Cell Lymphoma | Patrick Reagan | September 14, 2018 |
| NCT00591630 | Active, not recruiting | Diffuse Large Cell Lymphoma;Lymphoma | M.D. Anderson Cancer Center | November 8, 2018 |
| NCT02732236 | Recruiting | Lymphoma, B-Cell, Marginal Zone | Dong-A University Hospital | April 18, 2018 |
| NCT00759798 | Active, not recruiting | Chronic Lymphocytic Leukemia;Leukemia | M.D. Anderson Cancer Center | October 5, 2018 |
| NCT03366272 | Recruiting | Lymphoma, Non-Hodgkin | University Hospital, Saarland | October 18, 2018 |
| NCT00711828 | Active, not recruiting | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;Nodal Marginal Zone Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic Leukemia;Splenic Marginal Zone Lymphoma;Waldenstrom Macroglobulinemia; | Mayo Clinic | March 30, 2018 |
| NCT02600897 | Recruiting | Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Hoffmann-La Roche | November 30, 2018 |
| NCT02729896 | Active, not recruiting | Lymphoma | Hoffmann-La Roche | November 6, 2018 |
| NCT01768195 | Recruiting | Hepatitis B | Peking University | January 10, 2017 |
| NCT01329354 | Active, not recruiting | Follicular Lymphoma;Follicular Non-Hodgkin´s Lymphoma;Autologous Effector Lymphocytes | Clinica Universidad de Navarra, Universidad de Navarra | October 24, 2017 |
| NCT02369016 | Active, not recruiting | Lymphoma, Non-Hodgkin | Bayer | November 12, 2018 |
| NCT01479842 | Active, not recruiting | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Nodal Marginal Zone B-cell Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Splenic Marginal Zone Lymphoma;Waldenstrom Macroglobulinemia; | Kami Maddocks | November 9, 2017 |
| NCT03746223 | Not yet recruiting | Primary Intraocular Lymphoma | Peking Union Medical College Hospital | November 19, 2018 |
| NCT03456466 | Recruiting | Non-hodgkin's Lymphoma | Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd | March 7, 2018 |
| NCT00006436 | Recruiting | Lymphoma, AIDS-related;Lymphoma, Large B-Cell, Diffuse | National Cancer Institute (NCI) | October 11, 2018 |
| NCT03271515 | Not yet recruiting | Leukemia;Lymphoma | Beijing Doing Biomedical Co., Ltd. | September 5, 2017 |
| NCT02442648 | Recruiting | Transplants and Implants | E. Steve Woodle | August 8, 2018 |
| NCT03719989 | Not yet recruiting | Diffuse Large B Cell Lymphoma;Relapsed Non Hodgkin Lymphoma;Refractory Non-Hodgkin Lymphoma | Seoul National University Hospital | October 25, 2018 |
| NCT02776813 | Recruiting | Lymphoma | Unum Therapeutics Inc. | March 20, 2018 |
| NCT01776840 | Active, not recruiting | Mantle Cell Lymphoma | Janssen Research & Development, LLC | November 16, 2018 |
| NCT02950051 | Recruiting | Chronic Lymphocytic Leukemia | German CLL Study Group | June 25, 2018 |
| NCT00878254 | Recruiting | Mantle-Cell Lymphoma | University of Miami | September 20, 2018 |
| NCT01216683 | Active, not recruiting | Lymphoma | Eastern Cooperative Oncology Group | June 8, 2018 |
| NCT02867566 | Recruiting | Diffuse, Large B-Cell, Lymphoma | Innovent Biologics (Suzhou) Co. Ltd. | April 17, 2017 |
| NCT02717624 | Active, not recruiting | Mantle Cell Lymphoma (MCL) | Acerta Pharma BV | February 20, 2018 |
| NCT03312907 | Recruiting | Systemic Lupus Erythematosus | GlaxoSmithKline | October 12, 2018 |
| NCT00317096 | Active, not recruiting | Lymphoma, Follicular;Lymphoma, Low-Grade;Lymphoma, Intermediate-Grade | Ludwig-Maximilians - University of Munich | March 8, 2018 |
| NCT01399372 | Active, not recruiting | Chemotherapeutic Agent Toxicity;Cognitive/Functional Effects;Lymphoma;Neurotoxicity;Radiation Toxicity; | Radiation Therapy Oncology Group | December 26, 2017 |
| NCT02354313 | Active, not recruiting | MANTLE CELL LYMPHOMA | Fondazione Italiana Linfomi ONLUS | February 9, 2018 |
| NCT03078855 | Recruiting | Follicular Lymphoma;Small Lymphocytic Lymphoma;Marginal Zone Lymphoma;Mucosal-Associated Lymphoid Tissue Lymphoma; | Jonathan Friedberg | November 27, 2018 |
| NCT02954406 | Recruiting | Lymphoma, Non-Hodgkin | Millennium Pharmaceuticals, Inc. | September 7, 2018 |
| NCT01670370 | Active, not recruiting | Diffuse Large B-cell Lymphoma | The First Affiliated Hospital with Nanjing Medical University | April 11, 2018 |
| NCT02758925 | Not yet recruiting | Diffuse Large B Cell Lymphoma | University Hospital, Caen | May 4, 2016 |
| NCT03584802 | Not yet recruiting | Exacerbation of Idiopathic Pulmonary Fibrosis | Assistance Publique - Hôpitaux de Paris | July 12, 2018 |
| NCT01193842 | Active, not recruiting | AIDS-Related Plasmablastic Lymphoma;AIDS-Related Primary Effusion Lymphoma;Ann Arbor Stage I Diffuse Large B-Cell Lymphoma;Ann Arbor Stage I Grade 3 Follicular Lymphoma;Ann Arbor Stage II Diffuse Large B-Cell Lymphoma;Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma;Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma;Ann Arbor Stage III Diffuse Large B-Cell Lymphoma;Ann Arbor Stage III Grade 3 Follicular Lymphoma;Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma;Ann Arbor Stage IV Grade 3 Follicular Lymphoma;CD20 Positive;HIV Infection;Plasmablastic Lymphoma;Primary Effusion Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Grade 3 Follicular Lymphoma; | National Cancer Institute (NCI) | October 31, 2018 |
| NCT01035463 | Active, not recruiting | Adult Nasal Type Extranodal NK/T-cell Lymphoma;Anaplastic Large Cell Lymphoma;Angioimmunoblastic T-cell Lymphoma;Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Nodal Marginal Zone B-cell Lymphoma;Peripheral T-cell Lymphoma;Recurrent Adult Burkitt Lymphoma;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Diffuse Mixed Cell Lymphoma;Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;Recurrent Adult Grade III Lymphomatoid Granulomatosis;Recurrent Adult Immunoblastic Large Cell Lymphoma;Recurrent Adult Lymphoblastic Lymphoma;Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;Recurrent Grade 1 Follicular Lymphoma;Recurrent Grade 2 Follicular Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma;Recurrent Marginal Zone Lymphoma;Recurrent Mycosis Fungoides/Sezary Syndrome;Recurrent Small Lymphocytic Lymphoma;Splenic Marginal Zone Lymphoma;Stage III Adult Burkitt Lymphoma;Stage III Adult Diffuse Large Cell Lymphoma;Stage III Adult Diffuse Mixed Cell Lymphoma;Stage III Adult Diffuse Small Cleaved Cell Lymphoma;Stage III Adult Immunoblastic Large Cell Lymphoma;Stage III Adult Lymphoblastic Lymphoma;Stage III Grade 1 Follicular Lymphoma;Stage III Cutaneous T-cell Non-Hodgkin Lymphoma;Stage III Grade 2 Follicular Lymphoma;Stage III Grade 3 Follicular Lymphoma;Stage III Mantle Cell Lymphoma;Stage III Marginal Zone Lymphoma;Stage III Mycosis Fungoides/Sezary Syndrome;Stage III Small Lymphocytic Lymphoma;Stage IV Adult Burkitt Lymphoma;Stage IV Adult Diffuse Large Cell Lymphoma;Stage IV Adult Diffuse Mixed Cell Lymphoma;Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;Stage IV Adult Immunoblastic Large Cell Lymphoma;Stage IV Adult Lymphoblastic Lymphoma;Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma;Stage IV Grade 3 Follicular Lymphoma;Stage IV Mantle Cell Lymphoma;Stage IV Marginal Zone Lymphoma;Stage IV Mycosis Fungoides/Sezary Syndrome;Stage IV Small Lymphocytic Lymphoma;Waldenström Macroglobulinemia; | University of Nebraska | January 17, 2018 |
| NCT01974440 | Active, not recruiting | Lymphoma | Janssen Research & Development, LLC | November 16, 2018 |
| NCT00477412 | Active, not recruiting | Mantle Cell Lymphoma | M.D. Anderson Cancer Center | September 20, 2018 |
| NCT01855750 | Active, not recruiting | Lymphoma | Janssen Research & Development, LLC | November 21, 2018 |
| NCT00972478 | Active, not recruiting | Ann Arbor Stage II Non-Hodgkin Lymphoma;Ann Arbor Stage III Non-Hodgkin Lymphoma;Ann Arbor Stage IV Non-Hodgkin Lymphoma | National Cancer Institute (NCI) | October 31, 2018 |
| NCT01992653 | Active, not recruiting | Lymphoma, Non Hodgkin | Genentech, Inc. | October 19, 2018 |
| NCT02596971 | Active, not recruiting | Diffuse Large B-Cell Lymphoma, Lymphoma Follicular | Hoffmann-La Roche | October 30, 2018 |
| NCT03737136 | Recruiting | Antibody-mediated Rejection | Shahid Beheshti University of Medical Sciences | November 9, 2018 |
| NCT02633137 | Active, not recruiting | Mantle Cell Lymphoma;Untreated | Memorial Sloan Kettering Cancer Center | November 8, 2018 |
| NCT01448096 | Active, not recruiting | Large B Cell Diffuse Lymphoma | Chonbuk National University Hospital | August 29, 2017 |
| NCT01415752 | Recruiting | Lymphoma;Neurotoxicity;Therapy-related Toxicity | Eastern Cooperative Oncology Group | March 20, 2017 |
| NCT00134082 | Active, not recruiting | Lymphoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | November 6, 2017 |
| NCT03467373 | Recruiting | B-Cell Lymphoma;Non-Hodgkin Lymphoma | Hoffmann-La Roche | November 5, 2018 |
| NCT00732498 | Active, not recruiting | Lymphoma | University of Arizona | October 15, 2018 |
| NCT03399747 | Enrolling by invitation | Diffuse Large B-cell Lymphoma | Asan Medical Center | January 16, 2018 |
| NCT02073097 | Recruiting | Contiguous Stage II Adult Diffuse Large Cell Lymphoma;Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;Stage I Adult Diffuse Large Cell Lymphoma;Stage III Adult Diffuse Large Cell Lymphoma;Stage IV Adult Diffuse Large Cell Lymphoma; | Case Comprehensive Cancer Center | October 5, 2018 |
| NCT00209209 | Active, not recruiting | Lymphoma, Mantle-Cell | European Mantle Cell Lymphoma Network | March 7, 2017 |
| NCT03569995 | Recruiting | Primary CNS Lymphoma | Won Seog Kim | September 6, 2018 |
| NCT02993536 | Recruiting | Chronic Lymphocytic Leukemia | Abramson Cancer Center of the University of Pennsylvania | December 15, 2016 |
| NCT03392142 | Recruiting | Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder | Atara Biotherapeutics | October 18, 2018 |
| NCT03394365 | Recruiting | Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorder | Atara Biotherapeutics | October 18, 2018 |
| NCT01788189 | Recruiting | B-cell Lymphoma | University Hospital, Essen | May 8, 2018 |
| NCT02670616 | Recruiting | Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma | Samsung Medical Center | April 20, 2018 |
| NCT02251548 | Active, not recruiting | Chronic Lymphocytic Leukemia;Leukemia | Dana-Farber Cancer Institute | May 7, 2018 |
| NCT03019640 | Recruiting | Mantle Cell Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Indolent Adult Non-Hodgkin Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Refractory Indolent Adult Non-Hodgkin Lymphoma; | M.D. Anderson Cancer Center | September 19, 2018 |
| NCT03567876 | Not yet recruiting | Lymphoma, Mantle-Cell | Fondazione Italiana Linfomi ONLUS | July 9, 2018 |
| NCT02158091 | Active, not recruiting | Chronic Lymphocytic Leukemia | Dana-Farber Cancer Institute | December 20, 2017 |
| NCT02772822 | Not yet recruiting | Diffuse Large B Cell Lymphoma | Sinocelltech Ltd. | May 16, 2016 |
| NCT02315118 | Recruiting | B-Cell Chronic Lymphocytic Leukemia;Non-Hodgkin's Lymphoma | National University Hospital, Singapore | June 22, 2016 |
| NCT00078949 | Active, not recruiting | Lymphoma | NCIC Clinical Trials Group | March 12, 2018 |
| NCT01788020 | Recruiting | Waldenström's Macroglobulinemia | University of Ulm | March 19, 2018 |
| NCT03440567 | Recruiting | CCND1 Positive;CD20 Positive;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Mantle Cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Mantle Cell Lymphoma;Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; | City of Hope Medical Center | October 9, 2018 |
| NCT02858258 | Recruiting | Mantle Cell Lymphoma | Prof. Dr. M. Dreyling (co-chairman) | December 19, 2017 |
| NCT00267865 | Recruiting | Lymphoma-AIDS-Related;Brain Neoplasm | National Cancer Institute (NCI) | September 24, 2018 |
| NCT01077518 | Active, not recruiting | Lymphoma, Follicular | Novartis Pharmaceuticals | October 4, 2018 |
| NCT02834468 | Recruiting | Immune Thrombocytopenia | Shandong University | July 15, 2016 |
| NCT03274492 | Recruiting | Diffuse Large B-Cell Lymphoma | Hoffmann-La Roche | November 16, 2018 |
| NCT03121677 | Recruiting | Follicular Lymphoma | Washington University School of Medicine | November 14, 2018 |
| NCT02055820 | Active, not recruiting | Lymphoma, Non-Hodgkin | Hoffmann-La Roche | March 27, 2018 |
| NCT02203526 | Recruiting | Primary Central Nervious System Lymphoma | National Cancer Institute (NCI) | November 21, 2018 |
| NCT00670358 | Recruiting | Lymphoma | Mayo Clinic | June 7, 2018 |
| NCT03458260 | Recruiting | Aggressive Non-Hodgkin Lymphoma | The Lymphoma Academic Research Organisation | April 6, 2018 |
| NCT02628405 | Recruiting | CD20 Positive;Recurrent B-Cell Non-Hodgkin Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Recurrent Transformed Non-Hodgkin Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Refractory Transformed Non-Hodgkin Lymphoma; | Academic and Community Cancer Research United | July 26, 2018 |
| NCT01092182 | Active, not recruiting | Burkitt Lymphoma;Diffuse Large B-cell Lymphoma, c-MYC Positive;Plasmablastic Lymphoma; | National Cancer Institute (NCI) | August 9, 2018 |
| NCT03507348 | Not yet recruiting | End-stage Renal Disease;Kidney Transplantation;Hla-incompatible Kidney Transplant Candidates | University Hospital, Grenoble | April 25, 2018 |
| NCT02678299 | Recruiting | Malignant Lymphoma | University of Aarhus | February 9, 2016 |
| NCT01599559 | Recruiting | Primary Mediastinal B-cell Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | October 25, 2018 |
| NCT03650933 | Not yet recruiting | Diffuse Large B-Cell Lymphoma, Unspecified Site | Nanjing Yoko Biomedical Co., Ltd. | August 29, 2018 |
| NCT01059630 | Active, not recruiting | Non-Hodgkin's Lymphoma | Genentech, Inc. | September 24, 2018 |
| NCT01679119 | Recruiting | Diffuse Large B Cell Lymphoma | University College, London | May 3, 2018 |
| NCT01449344 | Active, not recruiting | Mantle Cell Lymphoma | Prof. Dr. M. Dreyling (co-chairman) | March 7, 2017 |
| NCT00515554 | Active, not recruiting | Hodgkins Lymphoma | University of Cologne | March 22, 2018 |
| NCT00278538 | Active, not recruiting | Systemic Lupus Erythematosus | Northwestern University | July 16, 2018 |
| NCT03747159 | Recruiting | Lupus Erythematosus, Systemic | Leiden University Medical Center | November 30, 2018 |
| NCT00114738 | Active, not recruiting | Lymphoma, Mantle Cell;Mantle Cell Lymphoma | National Cancer Institute (NCI) | July 3, 2018 |
| NCT01416974 | Active, not recruiting | Leukemia | Memorial Sloan Kettering Cancer Center | September 5, 2018 |
| NCT02692248 | Recruiting | Diffuse Large B-Cell Lymphoma | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | June 27, 2018 |
| NCT02199184 | Recruiting | Leukemia | M.D. Anderson Cancer Center | December 2, 2017 |
| NCT03027999 | Recruiting | Rheumatoid Arthritis | University Hospital, Rouen | August 30, 2017 |
| NCT00115700 | Active, not recruiting | Follicular Lymphoma | Trans-Tasman Radiation Oncology Group (TROG) | July 12, 2017 |
| NCT03193866 | Recruiting | Relapsing-remitting Multiple Sclerosis | Karolinska Institutet | April 3, 2018 |
| NCT02752815 | Recruiting | Diffuse Large B-cell Lymphoma | Ruijin Hospital | May 4, 2018 |
| NCT01644253 | Active, not recruiting | Chronic Lymphocytic Leukemia;Peripheral T-cell Lymphoma | Aptevo Therapeutics | November 28, 2018 |
| NCT03349346 | Recruiting | Diffuse Large B-Cell Lymphoma;Mediastinal B-cell Lymphoma | Gilead Sciences | November 5, 2018 |
| NCT01664910 | Recruiting | Lymphoma;Leukemia | M.D. Anderson Cancer Center | September 14, 2018 |
| NCT03220022 | Recruiting | AIDS-Related Lymphoma;Ann Arbor Stage II Diffuse Large B-Cell Lymphoma;Ann Arbor Stage III Diffuse Large B-Cell Lymphoma;Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma;CD20 Negative;CD20 Positive;Human Immunodeficiency Virus Positive; | National Cancer Institute (NCI) | November 20, 2018 |
| NCT00274924 | Active, not recruiting | Lymphoma | Eastern Cooperative Oncology Group | November 21, 2017 |
| NCT00992030 | Active, not recruiting | Hodgkin Lymphoma | Fondazione Michelangelo | June 14, 2018 |
| NCT00863369 | Active, not recruiting | Lymphoma | City of Hope Medical Center | October 4, 2018 |
| NCT00812669 | Active, not recruiting | Leukemia | Cancer Trials Ireland | November 24, 2017 |
| NCT02911142 | Recruiting | Primary Effusion Lymphoma;B-Cell Lymphoma | National Cancer Institute (NCI) | August 31, 2018 |
| NCT02428751 | Recruiting | Lymphoma, Large B-Cell, Diffuse | Wenqi Jiang | November 18, 2015 |
| NCT01412879 | Active, not recruiting | Lymphoma | Southwest Oncology Group | March 14, 2018 |
| NCT02481310 | Recruiting | Adult Burkitt Lymphoma;B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;Diffuse Large B-Cell Lymphoma;MYC Gene Mutation;Plasmablastic Lymphoma; | Northwestern University | October 12, 2018 |
| NCT02694913 | Recruiting | Lymphoma | Weill Medical College of Cornell University | June 27, 2018 |
| NCT02367196 | Recruiting | Hematologic Neoplasms | Celgene | October 17, 2018 |
| NCT00118209 | Active, not recruiting | Large B Cell Lymphoma | Alliance for Clinical Trials in Oncology | July 10, 2018 |
| NCT03225924 | Recruiting | DLBCL | The Lymphoma Academic Research Organisation | November 26, 2018 |
| NCT00058422 | Active, not recruiting | Lymphoma | Memorial Sloan Kettering Cancer Center | March 2, 2018 |
| NCT03286556 | Recruiting | Idiopathic Pulmonary Fibrosis, Acute Fatal Form | University of Alabama at Birmingham | September 5, 2018 |
| NCT02313389 | Recruiting | Primary Central Nervous System Lymphoma | Assistance Publique - Hôpitaux de Paris | March 2, 2018 |
| NCT02414022 | Active, not recruiting | Chronic Lymphocytic Leukemia | Canadian Cancer Trials Group | March 29, 2018 |
| NCT02483000 | Recruiting | Burkitt Lymphoma;CD20-Positive Neoplastic Cells Present;Diffuse Large B-Cell Lymphoma;Indolent Non-Hodgkin Lymphoma;Mantle Cell Lymphoma;Recurrent B-Cell Non-Hodgkin Lymphoma;Refractory Mature B-Cell Non-Hodgkin Lymphoma; | Fred Hutchinson Cancer Research Center | March 14, 2018 |
| NCT00577278 | Active, not recruiting | Graft Versus Host Disease;Leukemia;Lymphoma | City of Hope Medical Center | November 6, 2018 |
| NCT01085617 | Recruiting | Leukemia;Mucositis;Oral Complications | University College, London | October 15, 2018 |
| NCT03514979 | Not yet recruiting | Systemic Vasculitis | Cambridge University Hospitals NHS Foundation Trust | May 3, 2018 |
| NCT02296918 | Recruiting | Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma;Prolymphocytic Leukemia | Acerta Pharma BV | February 7, 2018 |
| NCT01868269 | Recruiting | Opsoclonus Myoclonus Syndrome;Neuroblastoma | Institut Curie | November 14, 2017 |
| NCT02677155 | Recruiting | Follicular Lymphoma | Oslo University Hospital | October 19, 2017 |
| NCT03684980 | Recruiting | Central Nervous System Lymphoma | Memorial Sloan Kettering Cancer Center | November 16, 2018 |
| NCT00070018 | Active, not recruiting | Lymphoma | Southwest Oncology Group | June 28, 2018 |
| NCT03524235 | Recruiting | Multiple Myeloma;CLL;Chronic Lymphocytic Leukemia;Lymphoma | Noah Merin | September 28, 2018 |
| NCT03274375 | Not yet recruiting | Anti-NMDAR Encephalitis | Assistance Publique - Hôpitaux de Paris | September 6, 2017 |
| NCT03505762 | Recruiting | B-Cell Non-Hodgkin Lymphoma | Wake Forest University Health Sciences | July 27, 2018 |
| NCT02585947 | Recruiting | Non-Hodgkin's Lymphoma, Burkitt's | Seoul National University Hospital | December 21, 2016 |
| NCT03151044 | Recruiting | Diffuse Large B-cell Lymphoma | FENG Ji-feng | May 12, 2017 |
| NCT02871869 | Recruiting | Diffuse, Large B-Cell, Lymphoma | Xinjiang Medical University | July 17, 2017 |
| NCT02858804 | Recruiting | Mantle Cell Lymphoma | Institute of Hematology & Blood Diseases Hospital | August 8, 2016 |
| NCT03513601 | Recruiting | Diffuse Large B Cell Lymphoma | Mingzhi Zhang | May 1, 2018 |
| NCT00006721 | Active, not recruiting | Lymphoma | Southwest Oncology Group | August 10, 2018 |
| NCT02500251 | Active, not recruiting | Renal Transplant Rejection | E. Steve Woodle | August 8, 2018 |
| NCT03188198 | Recruiting | Large B Cell Lymphoma | Mansoura University | July 6, 2017 |
| NCT03003520 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse | Celgene | September 11, 2018 |
| NCT02994927 | Active, not recruiting | ANCA-Associated Vasculitis | ChemoCentryx | September 20, 2018 |
| NCT01319981 | Active, not recruiting | Leukemia | M.D. Anderson Cancer Center | January 30, 2018 |
| NCT03417414 | Not yet recruiting | B Cell Lymphocytic Leukemia;B Cell Non-Hodgkin's Lymphoma | Ottawa Hospital Research Institute | February 7, 2018 |
| NCT03343834 | Recruiting | Epstein-Barr Viraemia;Hematologic Diseases;Allogeneic Disease | Assistance Publique - Hôpitaux de Paris | June 4, 2018 |
| NCT03576807 | Recruiting | Relapsed or Refractory B-cell Lymphomas | Xin Wang | July 3, 2018 |
| NCT03207178 | Recruiting | Recurrent or Refractory B Cell Malignancy | Shanghai Longyao Biotechnology Inc., Ltd. | July 2, 2017 |
| NCT03283202 | Recruiting | Diffuse B-Cell Lymphoma | Celgene | October 8, 2018 |
| NCT02710149 | Recruiting | Leukemia;Lymphoma | Southwest Hospital, China | November 13, 2017 |
| NCT03373019 | Recruiting | Chidamide;Lymphoma, B-Cell;Lymphoma, Large B-Cell, Diffuse;Neoplasm by Histology;Neoplasms;Lymphoproliferative Disorders;Lymphatic Diseases;Immunoproliferative Disorders;Immune System Diseases;Lymphoma, Non-Hodgkin;Cyclophosphamide;Rituximab;Gemcitabine;Cisplatin;Dexamethasone;HDAC Inhibitor; | Fudan University | December 14, 2017 |
| NCT01285765 | Active, not recruiting | DLBCL | The Lymphoma Academic Research Organisation | October 11, 2018 |
| NCT02399189 | Recruiting | Primary Central Nervous System Lymphoma | Jun Zhu | April 13, 2015 |
| NCT03096782 | Recruiting | Hematopoietic/Lymphoid Cancer | M.D. Anderson Cancer Center | July 27, 2018 |
| NCT03064867 | Active, not recruiting | Diffuse Large B-cell-lymphoma | Paolo Caimi, MD | July 18, 2018 |
| NCT03495960 | Not yet recruiting | Primary Central Nervous System Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | August 27, 2018 |
| NCT02340936 | Active, not recruiting | Diffuse Large B-cell Lymphoma | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | February 8, 2018 |
| NCT01186978 | Active, not recruiting | Diffuse Large B-cell Lymphoma | Duke University | January 23, 2018 |
| NCT01490723 | Active, not recruiting | Leukemia；Lymphoma | M.D. Anderson Cancer Center | November 8, 2018 |
| NCT02594384 | Recruiting | Lymphoma, Non-Hodgkin; Leukemai, Chronic Lymphocytic | Lam Therapeutics Inc. | June 8, 2018 |
| NCT00983619 | Active, not recruiting | B-cell Malignancies | MedImmune LLC | May 21, 2018 |
| NCT03259503 | Not yet recruiting | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic;Lymphoma | M.D. Anderson Cancer Center | September 6, 2018 |
| NCT00001379 | Recruiting | Lymphomatoid Granulomatosis;Granulomatosis, Lymphomatoid;Non-Hodgkins Lymphoma;Lymphoproliferative Disorder; | National Cancer Institute (NCI) | October 31, 2018 |
| NCT02846584 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse;Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma，Malignant; | Southwest Hospital, China | September 7, 2016 |
| NCT02354846 | Recruiting | B-cell Lymphoma | Yonsei University | July 17, 2018 |
| NCT02733042 | Active, not recruiting | Lymphoma;Leukemia, Lymphocytic, Chronic, B-Cell | Celgene | October 17, 2018 |
| NCT03436134 | Not yet recruiting | Kidney Transplantation;Antibody Mediated Rejection | University Hospital, Grenoble | February 26, 2018 |
| NCT00310037 | Active, not recruiting | Mantle Cell Lymphoma | Alliance for Clinical Trials in Oncology | July 31, 2018 |
| NCT03530683 | Recruiting | Lymphoma;Myeloma | Trillium Therapeutics Inc. | November 26, 2018 |
| NCT03736616 | Not yet recruiting | Diffuse Large B Cell Lymphoma | Swedish Medical Center | November 14, 2018 |
| NCT02589145 | Active, not recruiting | Lymphoma | M.D. Anderson Cancer Center | May 23, 2018 |
| NCT02531841 | Recruiting | Diffuse Large B-cell-lymphoma | University Hospital Freiburg | August 25, 2015 |
| NCT01700946 | Recruiting | Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia;Recurrent Childhood B-Lymphoblastic Lymphoma | St. Jude Children's Research Hospital | July 10, 2018 |
| NCT02663518 | Recruiting | Hematologic Malignancies;Solid Tumor | Trillium Therapeutics Inc. | October 29, 2018 |
| NCT03201471 | Recruiting | Diffuse Large B Cell Lymphoma | First Affiliated Hospital of Zhejiang University | August 2, 2018 |
| NCT03206671 | Recruiting | Mature B-cell Non-Hodgkin Lymphoma | University Hospital Muenster | August 10, 2018 |
| NCT00005780 | Active, not recruiting | Mantle Cell Lymphoma;Lymphoma, Mantle Cell | National Cancer Institute (NCI) | November 21, 2018 |
| NCT03731234 | Not yet recruiting | DLBCL | Fondazione Italiana Linfomi ONLUS | November 6, 2018 |
| NCT01619761 | Recruiting | Leukemia;Chronic Lymphocytic Leukemia | M.D. Anderson Cancer Center | October 5, 2018 |
| NCT00899431 | Active, not recruiting | Chronic Lymphocytic Leukemia | M.D. Anderson Cancer Center | July 9, 2018 |
| NCT01829958 | Recruiting | Non Hodgkin Lymphoma (NHL);Diffuse Large B-cell Lymphoma (DLBCL) | Memorial Sloan Kettering Cancer Center | September 14, 2018 |
| NCT03681535 | Not yet recruiting | Diffuse Large B Cell Lymphoma | Duke University | September 26, 2018 |
| NCT02018861 | Active, not recruiting | B-Cell Malignancies | Incyte Corporation | September 10, 2018 |
| NCT03117751 | Recruiting | Acute Lymphoblastic Leukemia;Acute Lymphoblastic Lymphoma | St. Jude Children's Research Hospital | July 11, 2018 |
| NCT01458730 | Active, not recruiting | Central Nervous System Lymphoma | University of Aarhus | November 16, 2012 |
| NCT01318317 | Active, not recruiting | Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent Adult Diffuse Mixed Cell Lymphoma;Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;Recurrent Grade 3 Follicular Lymphoma;Recurrent Mantle Cell Lymphoma; | City of Hope Medical Center | August 9, 2018 |
| NCT00945724 | Recruiting | Large B-cell Diffuse Lymphoma of Testis | International Extranodal Lymphoma Study Group (IELSG) | February 28, 2018 |
| NCT03019055 | Recruiting | CLL/SLL;Lymphomas Non-Hodgkin's B-Cell | Medical College of Wisconsin | October 5, 2018 |
| NCT03169790 | Not yet recruiting | Non Hodgkin Lymphoma | NantKwest, Inc. | October 30, 2017 |
| NCT03045471 | Not yet recruiting | To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma | Shanghai Public Health Clinical Center | February 7, 2017 |
| NCT02280525 | Active, not recruiting | Leukemia | M.D. Anderson Cancer Center | November 29, 2018 |
| NCT02916316 | Recruiting | Lymphoma;Large B-Cell;Diffuse Large B-Cell | Fondazione Italiana Linfomi ONLUS | May 23, 2018 |
| NCT02240407 | Recruiting | Pompe Disease | University of Florida | November 30, 2018 |
| NCT02737085 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse | Southwest Hospital, China | September 7, 2016 |
| NCT02471911 | Recruiting | Diffuse Large B-Cell Lymphoma | Weill Medical College of Cornell University | January 30, 2018 |
| NCT01811368 | Recruiting | Refractory Non Hodgkin Lymphoma;Relapsed Non Hodgkin Lymphoma | University of California, Davis | March 2, 2018 |
| NCT00787722 | Active, not recruiting | Devic's Disease | Northwestern University | July 17, 2018 |
| NCT01434472 | Recruiting | Post-Transplant Lymphoproliferative Disorder;Recurrent Adult Diffuse Large Cell Lymphoma;Recurrent B-Cell Non-Hodgkin Lymphoma;Recurrent Burkitt Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Burkitt Lymphoma;Refractory Diffuse Large B-Cell Lymphoma; | Fred Hutchinson Cancer Research Center | October 10, 2018 |
| NCT02285062 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse | Celgene | October 17, 2018 |
| NCT02626455 | Recruiting | Lymphoma, Non-Hodgkin | Bayer | November 9, 2018 |
| NCT01965132 | Recruiting | Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis | Seoul National University Hospital | June 6, 2018 |
| NCT02423915 | Active, not recruiting | Leukemia;Lymphoma | M.D. Anderson Cancer Center | January 17, 2018 |
| NCT02343536 | Active, not recruiting | Lymphoma, Large B-Cell, Diffuse;Lymphoma, Follicular | Celgene | December 2, 2017 |
| NCT03598725 | Recruiting | Hemophilia A With Inhibitor | Beijing Children's Hospital | July 25, 2018 |
| NCT03290456 | Not yet recruiting | Granulomatosis With Polyangitis | Hospices Civils de Lyon | October 16, 2017 |
| NCT02012088 | Active, not recruiting | Lymphoma | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | February 8, 2018 |
| NCT02063685 | Active, not recruiting | Follicular Non-Hodgkin's Lymphoma | Fondazione Italiana Linfomi ONLUS | November 20, 2018 |
| NCT02727803 | Recruiting | Leukemia;Lymphoma;Myeloma;Myeloproliferative Diseases; | M.D. Anderson Cancer Center | June 25, 2018 |
| NCT01780454 | Active, not recruiting | End Stage Renal Disease | Massachusetts General Hospital | April 21, 2017 |
| NCT03013218 | Recruiting | Metastatic Cancer;Solid Tumor;Advanced Cancer;NonHodgkin Lymphoma; | ALX Oncology Inc. | August 8, 2018 |
| NCT03380936 | Recruiting | Kidney Transplant Rejection | University of Colorado, Denver | October 12, 2018 |
| NCT02703272 | Recruiting | Lymphoma, Non-Hodgkin | Janssen Research & Development, LLC | November 15, 2018 |
| NCT02240316 | Active, not recruiting | Lymphoma, B-Cell, Lymphoma, Follicular | Hoffmann-La Roche | November 1, 2018 |
| NCT02186574 | Recruiting | Hepatitis B;Lymphoma;Non-Hodgkin | University Health Network, Toronto | October 1, 2018 |
| NCT03749018 | Not yet recruiting | Aggressive Non-Hodgkin Lymphoma;Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma;Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma;Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma;Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma;Diffuse Large B-Cell Lymphoma;High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements;High Grade B-Cell Lymphoma, Not Otherwise Specified;Indolent Non-Hodgkin Lymphoma;Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma;Transformed Non-Hodgkin Lymphoma; | Kami Maddocks | November 21, 2018 |
| NCT02541565 | Recruiting | Composite Lymphoma;Grade 3b Follicular Lymphoma;Stage I Diffuse Large B-Cell Lymphoma;Stage I Follicular Lymphoma;Stage II Diffuse Large B-Cell Lymphoma;Stage II Follicular Lymphoma;Stage III Diffuse Large B-Cell Lymphoma;Stage III Follicular Lymphoma;Stage IV Diffuse Large B-Cell Lymphoma;Stage IV Follicular Lymphoma; | University of Washington | November 12, 2018 |
| NCT01796171 | Recruiting | Non-Hodgkin Lymphoma;Follicular Lymphoma | Nordic Nanovector | September 12, 2018 |
| NCT03535298 | Not yet recruiting | Multiple Sclerosis, Relapsing-Remitting | The Cleveland Clinic | September 14, 2018 |
| NCT03576547 | Recruiting | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Philadelphia Chromosome Positive;Recurrent Acute Lymphoblastic Leukemia;Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive;Refractory Acute Lymphoblastic Leukemia;Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive; | M.D. Anderson Cancer Center | November 26, 2018 |
| NCT02213913 | Recruiting | Adult Grade III Lymphomatoid Granulomatosis;B-cell Chronic Lymphocytic Leukemia;Contiguous Stage II Adult Diffuse Large Cell Lymphoma;Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma;Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma;Contiguous Stage II Grade 1 Follicular Lymphoma;Contiguous Stage II Grade 2 Follicular Lymphoma;Contiguous Stage II Grade 3 Follicular Lymphoma;Contiguous Stage II Mantle Cell Lymphoma;Contiguous Stage II Marginal Zone Lymphoma;Contiguous Stage II Small Lymphocytic Lymphoma;Cutaneous B-cell Non-Hodgkin Lymphoma;Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;Intraocular Lymphoma;Nodal Marginal Zone B-cell Lymphoma;Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma;Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma;Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma;Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma;Noncontiguous Stage II Grade 1 Follicular Lymphoma;Noncontiguous Stage II Grade 2 Follicular Lymphoma;Noncontiguous Stage II Grade 3 Follicular Lymphoma;Noncontiguous Stage II Mantle Cell Lymphoma;Noncontiguous Stage II Marginal Zone Lymphoma;Noncontiguous Stage II Small Lymphocytic Lymphoma;Progressive Hairy Cell Leukemia, Initial Treatment;Small Intestine Lymphoma;Splenic Marginal Zone Lymphoma;Stage 0 Chronic Lymphocytic Leukemia;Stage I Adult Diffuse Large Cell Lymphoma;Stage I Adult Diffuse Mixed Cell Lymphoma;Stage I Adult Diffuse Small Cleaved Cell Lymphoma;Stage I Adult Hodgkin Lymphoma;Stage I Adult Immunoblastic Large Cell Lymphoma;Stage I Chronic Lymphocytic Leukemia;Stage I Grade 1 Follicular Lymphoma;Stage I Grade 2 Follicular Lymphoma;Stage I Grade 3 Follicular Lymphoma;Stage I Mantle Cell Lymphoma;Stage I Marginal Zone Lymphoma;Stage I Small Lymphocytic Lymphoma;Stage II Adult Hodgkin Lymphoma;Stage II Chronic Lymphocytic Leukemia;Stage II Small Lymphocytic Lymphoma;Stage III Adult Diffuse Large Cell Lymphoma;Stage III Adult Diffuse Mixed Cell Lymphoma;Stage III Adult Diffuse Small Cleaved Cell Lymphoma;Stage III Adult Hodgkin Lymphoma;Stage III Adult Immunoblastic Large Cell Lymphoma;Stage III Chronic Lymphocytic Leukemia;Stage III Grade 1 Follicular Lymphoma;Stage III Grade 2 Follicular Lymphoma;Stage III Grade 3 Follicular Lymphoma;Stage III Mantle Cell Lymphoma;Stage III Marginal Zone Lymphoma;Stage III Small Lymphocytic Lymphoma;Stage IV Adult Diffuse Large Cell Lymphoma;Stage IV Adult Diffuse Mixed Cell Lymphoma;Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;Stage IV Adult Hodgkin Lymphoma;Stage IV Adult Immunoblastic Large Cell Lymphoma;Stage IV Chronic Lymphocytic Leukemia;Stage IV Grade 1 Follicular Lymphoma;Stage IV Grade 2 Follicular Lymphoma;Stage IV Grade 3 Follicular Lymphoma;Stage IV Mantle Cell Lymphoma;Stage IV Marginal Zone Lymphoma;Stage IV Small Lymphocytic Lymphoma;Testicular Lymphoma;Untreated Hairy Cell Leukemia;Waldenström Macroglobulinemia; | University of Chicago | October 15, 2018 |
| NCT03522415 | Recruiting | Moderately to Severely Active Rheumatoid Arthritis | Shanghai Henlius Biotech | July 10, 2018 |
| NCT03200015 | Active, not recruiting | Diffuse Large B Cell Lymphoma | Hospital Universitario Dr. Jose E. Gonzalez | September 21, 2018 |
| NCT03332121 | Recruiting | CD20 Positive B Cell Non-Hodgkin's Lymphoma | Shanghai Pharmaceuticals Holding Co., Ltd | March 27, 2018 |
| NCT01419561 | Recruiting | KSHV Inflammatory Cytokine Syndrome (KICS);KSHV;HHV-8 | National Cancer Institute (NCI) | October 15, 2018 |
| NCT02405676 | Recruiting | Mature B-cell Non-Hodgkin Lymphoma | Children's Cancer Group, China | February 9, 2018 |
| NCT02960646 | Recruiting | Leukemia | M.D. Anderson Cancer Center | July 17, 2018 |
| NCT02315326 | Recruiting | Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL);Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL) | Memorial Sloan Kettering Cancer Center | July 13, 2018 |
| NCT03318835 | Recruiting | Thalidomide | Fudan University | October 24, 2017 |
| NCT02881086 | Recruiting | Acute Lymphoblastic Leukemia;Lymphoblastic Lymphoma | Goethe University | March 6, 2018 |
| NCT03488225 | Recruiting | Acute Lymphocytic Leukemia | M.D. Anderson Cancer Center | November 22, 2018 |
| NCT03536039 | Recruiting | Lymphoma, Large B-Cell, Diffuse | Andres J. M. Ferreri | May 24, 2018 |
| NCT00092222 | Recruiting | Lymphoproliferative Disorder;HHV-8;Malignancy;HIV | National Cancer Institute (NCI) | November 16, 2018 |
| NCT03194321 | Recruiting | End Stage Renal Disease | Cedars-Sinai Medical Center | June 21, 2018 |
| NCT03311126 | Recruiting | Mantle Cell Lymphoma;Non-hodgkin Lymphoma;Non Hodgkin Lymphoma | University of Wisconsin, Madison | April 25, 2018 |
| NCT02877303 | Recruiting | Leukemia;Acute Lymphoblastic Leukemia | M.D. Anderson Cancer Center | November 6, 2018 |
| NCT00324467 | Active, not recruiting | Lymphoma, Non-Hodgkin;Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma | British Columbia Cancer Agency | November 28, 2017 |
| NCT02265731 | Active, not recruiting | Non-Hodgkin Lymphoma (NHL);Multiple Myeloma (MM);Chronic Lymphocytic Leukemia (CLL);Small Lymphocytic Lymphoma (SLL);Acute Myeloid Leukemia (AML); | AbbVie | October 16, 2018 |
| NCT03695055 | Recruiting | High-risk Aggressive Lymphoma After Auto-HSCT | Fujian Medical University | October 3, 2018 |
| NCT02003222 | Recruiting | Acute Lymphoblastic Leukemia;Lymphoblastic Lymphoma;B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative;BCR/ABL1 Fusion Protein Negative;Untreated Adult Acute Lymphoblastic Leukemia; | National Cancer Institute (NCI) | November 19, 2018 |
| NCT03500731 | Recruiting | Idiopathic Pulmonary Fibrosis;Emphysema or COPD | Paul Szabolcs | July 19, 2018 |
| NCT03323476 | Recruiting | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;End Stage Renal Disease | Centre Hospitalier Departemental Vendee | November 22, 2018 |
| NCT03136146 | Recruiting | Hematopoietic/Lymphoid Cancer;Acute Lymphoblastic Leukemia;Lymphoblastic Lymphoma;Burkitt Leukemia/Lymphoma; | M.D. Anderson Cancer Center | September 5, 2018 |
| NCT02398240 | Recruiting | Hodgkin Lymphoma | Mitchell Cairo | December 22, 2017 |
| NCT01827605 | Recruiting | Relapsed Follicular Lymphoma | Fondazione Italiana Linfomi ONLUS | May 22, 2018 |
| NCT02314403 | Recruiting | Kidney Failure, Chronic;Renal Insufficiency | Massachusetts General Hospital | May 22, 2018 |
| NCT03161054 | Recruiting | Aggressive Non-Hodgkin Lymphoma | Fondazione Italiana Linfomi ONLUS | November 21, 2018 |
| NCT03016455 | Recruiting | Renal Transplant | University Hospital, Brest | May 4, 2017 |
| NCT01647971 | Active, not recruiting | Non-Hodgkins Lymphoma;B-cell Lymphoma;Waldenstrom's Macroglobulinemia;Marginal Zone Lymphoma;Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma;Primary Central Nervous System Lymphoma; | TG Therapeutics, Inc. | September 13, 2018 |
| NCT03412188 | Recruiting | Idiopathic Thrombocytopenic Purpura | Nayera Hazaa Elsherif | August 14, 2018 |
| NCT03036904 | Recruiting | Diffuse Large B-Cell Lymphoma;High Grade B-Cell Lymphoma | Weill Medical College of Cornell University | May 21, 2018 |
| NCT01556776 | Active, not recruiting | Chronic Lymphocytic Leukemia | German CLL Study Group | May 10, 2018 |
| NCT01046825 | Recruiting | Mature B-Cell Lymphoma | St. Jude Children's Research Hospital | July 10, 2018 |
| NCT00875667 | Active, not recruiting | Mantle Cell Lymphoma;Lymphoma, Mantle-Cell | Celgene | October 17, 2018 |
| NCT02059239 | Recruiting | Hodgkin's Lymphoma;Non-Hodgkin's Lymphoma | Weill Medical College of Cornell University | December 13, 2017 |
| NCT03593902 | Recruiting | Systemic Sclerosis;Scleroderma | Northwestern University | September 12, 2018 |
| NCT00701701 | Active, not recruiting | Pompe Disease;Glycogen Storage Disease Type II (GSD-II);Glycogenesis 2 Acid Maltase Deficiency | Genzyme, a Sanofi Company | March 23, 2018 |
| NCT02329080 | Recruiting | Diffuse Large B-cell Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | March 27, 2018 |
| NCT03018626 | Recruiting | Lymphoma, Large B-Cell, Diffuse | Nanfang Hospital of Southern Medical University | July 28, 2017 |
| NCT03147612 | Recruiting | Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia With BCR-ABL1;Philadelphia Chromosome Positive;Recurrent Acute Lymphoblastic Leukemia;Refractory Acute Lymphoblastic Leukemia; | M.D. Anderson Cancer Center | October 17, 2018 |
| NCT02753647 | Recruiting | Diffuse Large B-cell Lymphoma | Ruijin Hospital | November 14, 2017 |
| NCT02337985 | Active, not recruiting | AIDS-Related Burkitt Lymphoma;AIDS-Related Diffuse Large B-cell Lymphoma;AIDS-Related Plasmablastic Lymphoma;AIDS-Related Primary Effusion Lymphoma;HIV Infection;AIDS Related Non-Hodgkin Lymphoma; | City of Hope Medical Center | November 19, 2018 |
| NCT03269292 | Not yet recruiting | Autoimmune Hemolytic Anemia | Assiut University | August 31, 2017 |
| NCT02689869 | Active, not recruiting | Indolent Non-Hodgkin Lymphoma | Ludwig-Maximilians - University of Munich | September 19, 2018 |
| NCT03630211 | Recruiting | Systemic Sclerosis;SclerodermaDiffuse Sclerosis Systemic;Interstitial Lung Disease;Pulmonary Hypertension; | Paul Szabolcs | August 27, 2018 |
| NCT02790515 | Recruiting | Acute Lymphoblastic Leukemia (ALL);Acute Myeloid Leukemia (AML);Myeloid Sarcoma;Chronic Myeloid Leukemia (CML);Juvenile Myelomonocytic Leukemia (JMML);Myelodysplastic Syndrome (MDS);Non-Hodgkin Lymphoma (NHL); | St. Jude Children's Research Hospital | January 5, 2018 |
| NCT00001392 | Recruiting | AIDS Associated Nephropathy;Focal Glomerulosclerosis;HIV Infections; | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | November 9, 2018 |
| NCT03717103 | Not yet recruiting | Advanced Malignancies | Innovent Biologics (Suzhou) Co. Ltd. | October 25, 2018 |
| NCT02951156 | Active, not recruiting | Diffuse Large B-Cell Lymphoma | Pfizer | November 28, 2018 |
| NCT03742258 | Not yet recruiting | November 15, 2018 | ||
| NCT02767674 | Recruiting | Diffuse Large B Cell Lymphoma | The First Affiliated Hospital with Nanjing Medical University | April 11, 2018 |
| NCT01359592 | Active, not recruiting | Lymphoma | Southwest Oncology Group | October 10, 2018 |
| NCT01027000 | Active, not recruiting | Leukemia;Lymphoma | Alliance for Clinical Trials in Oncology | June 12, 2017 |
| NCT02043587 | Active, not recruiting | Acute Lymphocytic Leukemia;Adult Lymphoblastic Lymphoma | University of California, San Diego | October 19, 2018 |
| NCT02951728 | Recruiting | Diffuse Large B Cell Lymphoma | Ruijin Hospital | November 14, 2017 |
| NCT03579927 | Not yet recruiting | CD19 Positive;Mantle Cell Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Refractory B-Cell Non-Hodgkin Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma; | M.D. Anderson Cancer Center | October 12, 2018 |
| NCT03620578 | Recruiting | Non Hodgkin Lymphoma;Lymphoma, B-Cell;High-grade B-cell Lymphoma;MYC Translocation;BCL-2 Translocation; | Stichting Hemato-Oncologie voor Volwassenen Nederland | August 14, 2018 |
| NCT02779283 | Recruiting | Acute Lymphoblastic Leukemia;Acute Myeloid Leukemia | OHSU Knight Cancer Institute | August 3, 2018 |
| NCT03704714 | Not yet recruiting | Aggressive Non-Hodgkin Lymphoma;B-Cell Non-Hodgkin Lymphoma;CD20 Positive;Diffuse Large B-Cell Lymphoma Unclassifiable;Intravascular Large B-Cell Lymphoma;Primary Mediastinal (Thymic) Large B-Cell Lymphoma;T-Cell/Histiocyte-Rich Large B-Cell Lymphoma;Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; | Northwestern University | October 15, 2018 |
| NCT03432741 | Recruiting | Breast Adenocarcinoma;Recurrent Breast Carcinoma;Recurrent Hodgkin Lymphoma;Recurrent Mycosis Fungoides;Recurrent Non-Hodgkin Lymphoma;Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;Refractory Hodgkin Lymphoma;Refractory Mycosis Fungoides;Refractory Nodal Marginal Zone Lymphoma;Refractory Non-Hodgkin Lymphoma;Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma;Stage IV Breast Cancer AJCC v6 and v7; | Mayo Clinic | March 29, 2018 |
| NCT02738775 | Active, not recruiting | Multiple Sclerosis | TG Therapeutics, Inc. | September 13, 2018 |
| NCT03518112 | Recruiting | Leukemia;Acute Lymphoblastic Leukemia | M.D. Anderson Cancer Center | August 16, 2018 |
| NCT03023046 | Recruiting | Adult Acute Lymphoblastic Leukemia;Adult Lymphoblastic Lymphoma;Philadelphia Chromosome Positive; | University of Washington | December 4, 2017 |
| NCT02293109 | Recruiting | Contiguous Stage II Adult Lymphoblastic Lymphoma;Noncontiguous Stage II Adult Lymphoblastic Lymphoma;Stage I Adult Lymphoblastic Lymphoma;Stage III Adult Lymphoblastic Lymphoma;Stage IV Adult Lymphoblastic Lymphoma;Untreated Adult Acute Lymphoblastic Leukemia; | University of California, Davis | March 2, 2018 |
| NCT02741388 | Recruiting | B-cell Lymphoma | The Lymphoma Academic Research Organisation | October 11, 2018 |
| NCT02499003 | Active, not recruiting | Lymphoma, Non-Hodgkin | Johannes Gutenberg University Mainz | November 29, 2018 |
| NCT02651662 | Recruiting | Lymphoma | Regeneron Pharmaceuticals | September 11, 2018 |
| NCT02282514 | Recruiting | Stiff-Person Syndrome | Northwestern University | March 29, 2018 |
| NCT02290951 | Recruiting | Non-Hodgkin's Lymphoma;Chronic Lymphocytic Leukemia | Regeneron Pharmaceuticals | August 20, 2018 |
| NCT03418038 | Recruiting | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Hodgkin Lymphoma;Recurrent Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Lymphoma; | Mayo Clinic | March 27, 2018 |
| NCT02006485 | Active, not recruiting | Chronic Lymphocytic Leukemia;Non-Hodgkin's Lymphoma | TG Therapeutics, Inc. | September 13, 2018 |
| NCT03322865 | Not yet recruiting | Marginal Zone Lymphoma | Christian Buske | October 26, 2017 |
| NCT02356159 | Recruiting | Myelodysplastic Syndrome;Hodgkin's Lymphoma;Non-Hodgkin's Lymphoma;Acute Leukemia;Multiple Myeloma; | National Cancer Institute (NCI) | October 15, 2018 |
| NCT00566696 | Active, not recruiting | Leukemia, Acute Lymphocytic (ALL);Leukemia, Myeloid, Acute(AML);Leukemia, Myeloid, Chronic(CML);Juvenile Myelomonocytic Leukemia (JMML);Hemoglobinuria, Paroxysmal Nocturnal (PNH);Hodgkin Lymphoma;Lymphoma, Non-Hodgkin (NHL);Myelodysplastic Syndrome (MDS); | St. Jude Children's Research Hospital | May 11, 2018 |
| NCT02890602 | Active, not recruiting | Diffuse Large B-cell Lymphoma | Kosin University Gospel Hospital | August 8, 2018 |
| NCT01994382 | Recruiting | Follicular Lymphoma (FL/Indolent NHL);Aggressive NHL (a NHL);Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL);T-cell Lymphoma (PTCL and CTCL);B-cell Non Hodgkin Lymphoma (NHL); | Portola Pharmaceuticals | September 24, 2018 |
| NCT02652468 | Active, not recruiting | Lymphoma | University of Wisconsin, Madison | November 7, 2018 |
| NCT02229422 | Active, not recruiting | CLL | University of California, San Diego | March 27, 2018 |
| NCT03570892 | Not yet recruiting | Non-Hodgkin Lymphoma | Novartis Pharmaceuticals | October 29, 2018 |
| NCT02436707 | Recruiting | Lymphoma | Canadian Cancer Trials Group | November 14, 2018 |
| NCT02546492 | Recruiting | Transplant Glomerulopathy | University of Maryland | November 21, 2017 |
| NCT03531736 | Recruiting | Myeloid Diseases | Memorial Sloan Kettering Cancer Center | November 20, 2018 |
| NCT03600363 | Not yet recruiting | Lymphoma, Large B-Cell, Diffuse;Stage III Follicular Lymphoma | Ruijin Hospital | August 22, 2018 |
| NCT01882803 | Active, not recruiting | Indolent Non-Hodgkin Lymphoma | Verastem, Inc. | November 20, 2018 |
| NCT01994850 | Active, not recruiting | CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30 Positive Diffuse Large B-cell Lymphoma or CD30 Positive Grey Zone Lymphoma | Abramson Cancer Center of the University of Pennsylvania | July 6, 2017 |
| NCT01685008 | Active, not recruiting | Non-Hodgkin Lymphoma | MorphoSys AG | January 17, 2018 |
| NCT01555541 | Recruiting | Diffuse Large Cell Lymphoma Relapsed/Refractory | C. Babis Andreadis | June 9, 2017 |
| NCT03054896 | Recruiting | Richter Syndrome | Dana-Farber Cancer Institute | March 21, 2018 |
| NCT03605238 | Not yet recruiting | Neuromyelitis Optica Spectrum Disorder | Chinese PLA General Hospital | July 30, 2018 |
| NCT03653338 | Recruiting | Sickle Cell Anemia;Beta-thalassemia Major;Diamond-blackfan Anemia | Beth Carella, DO | October 3, 2018 |
| NCT02276963 | Active, not recruiting | Neuromyelitis Optica;Neuromyelitis Optica Spectrum Disorder | Johns Hopkins University | September 28, 2018 |
| NCT02361346 | Recruiting | Non-Hodgkin's B-cell Lymphoma;Leukemia, Lymphocytic, Chronic, B-Cell;Small Lymphocytic Leukemia | Molecular Templates, Inc. | November 5, 2018 |
| NCT02420717 | Recruiting | Leukemia | M.D. Anderson Cancer Center | September 14, 2018 |
| NCT03288584 | Recruiting | Rheumatoid Arthritis;Inflammation | University of Athens | July 9, 2018 |
| NCT01701986 | Recruiting | Lymphoma | M.D. Anderson Cancer Center | January 26, 2018 |
| NCT00345865 | Active, not recruiting | Lymphoma | Masonic Cancer Center, University of Minnesota | September 26, 2018 |
| NCT03263026 | Recruiting | Diffuse Large B-Cell Lymphoma | Denovo Biopharma LLC | November 14, 2018 |
| NCT00520130 | Active, not recruiting | Myelodysplastic Syndrome;Hodgkin's Lymphoma;Non-Hodgkin's Disease;Acute Leukemia;Multiple Myeloma; | National Cancer Institute (NCI) | June 7, 2018 |
| NCT02623010 | Recruiting | Central Nervous System Lymphoma | Rabin Medical Center | April 12, 2018 |
| NCT02836158 | Recruiting | Primary Central Nervous System Lymphoma | Navy General Hospital, Beijing | April 6, 2018 |
| NCT02657785 | Enrolling by invitation | Primary Central Nervous System Lymphoma | Navy General Hospital, Beijing | April 6, 2018 |
| NCT03681938 | Active, not recruiting | Lymphoma, B-Cell | Institut Paoli-Calmettes | September 24, 2018 |
| NCT03651518 | Not yet recruiting | Inflammatory Disease;Autoimmune Diseases | Assistance Publique - Hôpitaux de Paris | August 29, 2018 |
| NCT02525172 | Recruiting | Pompe Disease | National Taiwan University Hospital | April 15, 2016 |
| NCT03293173 | Recruiting | Lymphoma, Large B-Cell, Diffuse | Nordic Lymphoma Group | September 26, 2017 |
| NCT03616782 | Not yet recruiting | Mantle Cell Lymphoma | Ho Sup Lee | August 6, 2018 |
| NCT03715309 | Not yet recruiting | Follicular Lymphoma | Ruijin Hospital | October 23, 2018 |
| NCT02438501 | Recruiting | Recurrent Follicular Lymphoma | Di Deng | December 14, 2015 |
| NCT03664635 | Not yet recruiting | Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma;Non-Hodgkin's Lymphoma;Refractory/Relapsed CD20+ B-NHL | Miltenyi Biotec GmbH | September 10, 2018 |
| NCT03283137 | Recruiting | CLL;B-cell Non Hodgkin Lymphoma | University of Chicago | April 17, 2018 |
| NCT03429660 | Recruiting | Thrombocytopenia | University Hospital, Toulouse | February 12, 2018 |
| NCT01325194 | Active, not recruiting | Primary Disease | Nordic Lymphoma Group | September 7, 2017 |
| NCT03399513 | Recruiting | Diffuse Large B Cell Lymphoma | University Hospital Muenster | October 11, 2018 |
| NCT02280902 | Recruiting | Immunologic and Inflammatory Diseases | University Hospital, Bordeaux | September 20, 2018 |
| NCT03562975 | Recruiting | Multiple Sclerosis;Pathologic Processes;Demyelinating Diseases;Nervous System Diseases;Autoimmune Diseases;Immune System Diseases;Primary Progressive Multiple Sclerosis;Relapsing Remitting Multiple Sclerosis; | University of South Florida | October 16, 2018 |
| NCT02120482 | Recruiting | Decreased Immunologic Activity;Antibody-mediated Rejection | Medical University of Vienna | January 17, 2018 |
| NCT02877550 | Recruiting | Follicular Lymphoma | Swiss Group for Clinical Cancer Research | July 11, 2018 |
| NCT03392714 | Active, not recruiting | PCNSL | Chonnam National University Hospital | January 8, 2018 |
| NCT03477656 | Recruiting | Kidney Transplantation | University Hospital, Toulouse | June 8, 2018 |
| NCT03494296 | Recruiting | Lymphoma | First Affiliated Hospital of Harbin Medical University | April 11, 2018 |
| NCT03492255 | Recruiting | Systemic Lupus Erythematosus (SLE) | University of Sao Paulo General Hospital | April 17, 2018 |
| NCT02371161 | Recruiting | Non Hodgkin Lymphoma | Fondazione Italiana Linfomi ONLUS | April 25, 2018 |
| NCT03198026 | Recruiting | Non-Hodgkin's Lymphoma | Sidney Kimmel Cancer Center at Thomas Jefferson University | March 6, 2018 |
| NCT03244176 | Recruiting | Lymphomas Non-Hodgkin's B-Cell | Austin Health | August 10, 2017 |
| NCT03463057 | Recruiting | NHL;DLBCL | Stichting Hemato-Oncologie voor Volwassenen Nederland | September 18, 2018 |
| NCT03715296 | Not yet recruiting | Diffuse Large B Cell Lymphoma | Ruijin Hospital | October 23, 2018 |
| NCT01357733 | Recruiting | Lymphoma, Large B-Cell, Diffuse | The Catholic University of Korea | April 3, 2018 |
| NCT03123718 | Not yet recruiting | DLBCL | Chonnam National University Hospital | April 24, 2017 |
| NCT03579082 | Recruiting | Diffuse Large B Cell Lymphoma | Mingzhi Zhang | September 14, 2018 |
| NCT02490020 | Enrolling by invitation | Disorder Related to Renal Transplantation;Renal Transplant Rejection | Qipeng Sun | July 3, 2015 |
| NCT03187444 | Recruiting | Rheumatology;Cardiovascular Diseases;Arthritis, Rheumatoid;Spondyloarthritis; | University Hospital, Clermont-Ferrand | June 15, 2017 |
| NCT03671018 | Recruiting | B-cell Non-Hodgkin Lymphoma | Hoffmann-La Roche | October 26, 2018 |
| NCT03582254 | Recruiting | Primary Central Nervous System Lymphoma | Assistance Publique - Hôpitaux de Paris | July 10, 2018 |
| NCT03758989 | Not yet recruiting | DLBCL | University of Rochester | November 29, 2018 |
| NCT02526823 | Recruiting | Lymphoma, Non-Hodgkin;Hodgkin Disease | Shandong Provincial Hospital | April 19, 2016 |
| NCT01852370 | Enrolling by invitation | Severe Combined Immunodeficiency (SCID);Immunodeficiency With Predominant T-cell Defect, Unspecified;Severe Chronic Neutropenia;Chronic Granulomatous Disease (CGD);Hyper IgE Syndromes;Hyper IgM Deficiencies;Wiskott-Aldrich Syndrome;Mendelian Susceptibility to Mycobacterial Disease;Common Variable Immune Deficiency (CVID); | Paul Szabolcs | February 8, 2018 |
| NCT03630159 | Recruiting | Diffuse Large B-cell Lymphoma | Novartis Pharmaceuticals | November 20, 2018 |
| NCT02714634 | Not yet recruiting | Rheumatoid Arthritis;Insufficient Response to Methotrexate. | University Hospital, Strasbourg, France | March 21, 2016 |
| NCT00692939 | Recruiting | Crohn's Disease | Paul Szabolcs | August 27, 2018 |
| NCT01842672 | Recruiting | Acute Lymphoblastic Leukemia;Acute Myelogenous Leukemia;Lymphoblastic Lymphoma;Diffuse Large B-cell Lymphoma;Burkitt Lymphoma/Leukemia; | New York Medical College | March 29, 2018 |
| NCT03221348 | Not yet recruiting | Follicular Lymphoma | Cho Pharma Inc. | January 24, 2018 |
| NCT03276468 | Recruiting | Follicular Lymphoma;Genetic Predisposition to DiseaseDiffuse Large B Cell Lymphoma;Marginal Zone Lymphoma;Mucosa Associated Lymphoid Tissue; | The Lymphoma Academic Research Organisation | October 10, 2018 |
| NCT01862965 | Active, not recruiting | Chronic Graft-versus-host Disease | Universitätsklinikum Hamburg-Eppendorf | April 19, 2018 |
| NCT03280160 | Recruiting | Chronic Lymphocytic Leukemia | PETHEMA Foundation | September 13, 2017 |
| NCT02199145 | Recruiting | Membranous Nephropathy | Centre Hospitalier Universitaire de Nice | February 16, 2018 |
| NCT03691077 | Not yet recruiting | Multiple Sclerosis;Relapse;Primary Progressive Multiple Sclerosis | Assistance Publique - Hôpitaux de Paris | October 12, 2018 |
| NCT00101101 | Active, not recruiting | Lymphoma | H. Lee Moffitt Cancer Center and Research Institute | November 2, 2018 |
| NCT03131934 | Not yet recruiting | Post-transplant Lymphoproliferative Disease;Transplant-Related Hematologic Malignancy | University College, London | October 16, 2018 |
| NCT01852435 | Active, not recruiting | Diffuse Large B-cell Lymphoma;Follicular Lymphoma Grade 3B | Ruijin Hospital | November 14, 2017 |
| NCT03010358 | Recruiting | Anemia;B-Cell Prolymphocytic Leukemia;Fatigue;Fever;Grade 1 Follicular Lymphoma;Grade 2 Follicular LymphomaGrade 3a Follicular Lymphoma;Hairy Cell Leukemia;Lymphadenopathy;Lymphocytosis;Lymphoplasmacytic Lymphoma;Mantle Cell Lymphoma;Marginal Zone Lymphoma;Night Sweats;Recurrent Chronic Lymphocytic Leukemia;Recurrent Small Lymphocytic Lymphoma;Refractory Chronic Lymphocytic LeukemiaRefractory Small Lymphocytic Lymphoma;Richter Syndrome;Splenomegaly;Thrombocytopenia;Weight Loss; | OHSU Knight Cancer Institute | October 2, 2018 |
| NCT02498951 | Recruiting | CD20 Positive;Central Nervous System B-Cell Non-Hodgkin Lymphoma | OHSU Knight Cancer Institute | September 20, 2018 |
| NCT02736617 | Recruiting | Recurrent Mantle Cell Lymphoma;Refractory Mantle Cell Lymphoma | OHSU Knight Cancer Institute | September 25, 2017 |
| NCT03236857 | Recruiting | Malignancies;Acute Lymphoblastic Leukemia (ALL);Acute Myeloid Leukemia (AML);Non-Hodgkin's Lymphoma;Neuroblastoma; | AbbVie | November 22, 2018 |
| NCT03551275 | Active, not recruiting | Multiple Sclerosis | Biocad | July 17, 2018 |
| NCT03755947 | Not yet recruiting | B-Cell Chronic Lymphocytic Leukemia;B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) | Grupo Cooperativo de Hemopatías Malignas | November 29, 2018 |
| NCT03234140 | Not yet recruiting | Follicular Lymphoma;Genetic Predisposition to Disease | Hospices Civils de Lyon | July 31, 2017 |
| NCT03615105 | Recruiting | Acute Lymphoid Leukemia (ALL);Acute Myeloid Leukemia (AML);Chronic Myeloid Leukemia (CML);Hodgkin Lymphoma;Non-Hodgkin Lymphoma;Chronic Lymphocytic Leukemia; | Memorial Sloan Kettering Cancer Center | September 20, 2018 |
| NCT03049449 | Recruiting | Lymphoma, Large-Cell, Anaplasitc;Hodgkin Disease;Lymphoma, Hodgkins;Enteropathy-Associated T-Cell Lymphoma;Lymphoma, Extranodal NK-T-Cell; | National Cancer Institute (NCI) | September 25, 2018 |
| NCT03450343 | Not yet recruiting | Large B-Cell Diffuse Lymphoma | Medical University of South Carolina | July 16, 2018 |
| NCT03516617 | Recruiting | CCND1 Negative;Chronic Lymphocytic Leukemia;Refractory Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma;t(11;14) Negative; | Mayo Clinic | September 27, 2018 |
| NCT03019666 | Recruiting | Multiple Myeloma;Non-Hodgkin Lymphoma;Diffuse Large B Cell Lymphoma;Mantle-Cell Lymphoma;Follicular Lymphoma;Indolent B Cell Lymphoma;Primary Mediastinal Lymphoma;Lymphoplasmacytic Lymphoma; | Masonic Cancer Center, University of Minnesota | September 26, 2018 |
| NCT03679455 | Recruiting | Waldenstrom Macroglobulinemia | Polish Myeloma Consortium | November 12, 2018 |
| NCT03500328 | Recruiting | Multiple Sclerosis, Relapsing-Remitting | Johns Hopkins University | November 12, 2018 |
| NCT01578707 | Active, not recruiting | Relapsed or Refractory Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma | Pharmacyclics LLC. | May 25, 2018 |
| NCT02394106 | Recruiting | Nephrotic Syndrome | Istituto Giannina Gaslini | May 4, 2017 |
| NCT02135874 | Recruiting | Acute Bilineal Leukemia;Acute Biphenotypic Leukemia;Acute Leukemia of Ambiguous Lineage;Acute Undifferentiated Leukemia;Mixed Phenotype Acute Leukemia;Mixed Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified;Mixed Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified;Recurrent Mixed Phenotype Acute Leukemia; | M.D. Anderson Cancer Center | November 28, 2018 |
| NCT01424982 | Recruiting | Acute Lymphoblastic Leukemia;Adult Acute Lymphoblastic Leukemia in Complete Remission;B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1;Philadelphia Chromosome Positive;Untreated Adult Acute Lymphoblastic Leukemia; | M.D. Anderson Cancer Center | September 13, 2018 |
| NCT01371630 | Recruiting | Acute Lymphoblastic Leukemia;B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative;Untreated Adult Acute Lymphoblastic Leukemia | M.D. Anderson Cancer Center | October 26, 2018 |
| NCT00790413 | Active, not recruiting | Neuroblastoma | Lund University Hospital | March 14, 2017 |
| NCT03571308 | Recruiting | Non Hodgkin Lymphoma | University Hospital Southampton NHS Foundation Trust | June 27, 2018 |
| NCT03492775 | Recruiting | Indolent Non-hodgkin Lymphoma | Prof. Dr. Wolfgang Hiddemann | September 19, 2018 |
| NCT03737981 | Not yet recruiting | Chronic Lymphocytic Leukemia | National Cancer Institute (NCI) | November 12, 2018 |
| NCT02758314 | Not yet recruiting | Non-Small Cell Lung Cancer | Instituto Nacional de Cancerologia de Mexico | November 25, 2016 |
| NCT02427451 | Active, not recruiting | Chronic Lymphocytic Leukemia;Refractory Chronic Lymphocytic Leukemia | Kerry Rogers | November 21, 2017 |
| NCT02627417 | Recruiting | Adult Immune Thrombocytopenia (ITP);Dapsone | Assistance Publique - Hôpitaux de Paris | July 26, 2017 |
| NCT03701282 | Not yet recruiting | CCND1 Negative;Chronic Lymphocytic Leukemia;Small Lymphocytic Lymphoma;t(11;14) Negative | National Cancer Institute (NCI) | October 10, 2018 |
| NCT03112603 | Recruiting | Graft-versus-host Disease (GVHD) | Incyte Corporation | June 15, 2018 |
| NCT03571321 | Not yet recruiting | Acute Lymphoblastic Leukemia;ALL, Childhood;ALL | University of Chicago | October 15, 2018 |
| NCT03150693 | Recruiting | B Acute Lymphoblastic Leukemia | Alliance for Clinical Trials in Oncology | September 6, 2018 |
| NCT02871219 | Recruiting | Ann Arbor Stage II Grade 1 Follicular Lymphoma;Ann Arbor Stage II Grade 2 Follicular Lymphoma;Ann Arbor Stage III Grade 1 Follicular Lymphoma;Ann Arbor Stage III Grade 2 Follicular Lymphoma;Ann Arbor Stage IV Grade 1 Follicular Lymphoma;Ann Arbor Stage IV Grade 2 Follicular Lymphoma;Bulky Disease;Fatigue;Fever;Grade 3a Follicular Lymphoma;Night Sweats;Splenomegaly;Weight Loss; | M.D. Anderson Cancer Center | November 16, 2018 |
| NCT01361711 | Active, not recruiting | Stage I Chronic Lymphocytic Leukemia;Stage II Chronic Lymphocytic Leukemia;Stage III Chronic Lymphocytic Leukemia;Stage IV Chronic Lymphocytic Leukemia; | Northwestern University | February 16, 2018 |
| NCT03379051 | Recruiting | Chronic Lymphocytic Leukemia | TG Therapeutics, Inc. | October 9, 2018 |
| NCT02535286 | Recruiting | Chronic Lymphocytic Leukemia | TG Therapeutics, Inc. | September 26, 2018 |
| NCT02476084 | Recruiting | Rheumatoid Arthritis | University of Oxford | October 25, 2017 |
| NCT03479918 | Recruiting | Lymphoma, High-Grade | Elena N.Parovichnikova | March 27, 2018 |
| NCT02842931 | Recruiting | Diffuse Large B-Cell Lymphoma | National Research Center for Hematology, Russia | July 25, 2016 |
| NCT03330795 | Recruiting | Primary Immunodeficiency;PID | National Institute of Allergy and Infectious Diseases (NIAID) | November 24, 2017 |
| NCT02992522 | Recruiting | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Recurrent Burkitt Lymphoma;Recurrent Diffuse Large B-Cell Lymphoma;Recurrent Follicular Lymphoma;Recurrent Marginal Zone Lymphoma;Refractory Burkitt Lymphoma;Refractory Diffuse Large B-Cell Lymphoma;Refractory Follicular Lymphoma;Transformed Recurrent Non-Hodgkin Lymphoma; | Beth Christian | November 21, 2018 |
| NCT02750670 | Active, not recruiting | Lymphoma, Non-Hodgkin's | University Health Network, Toronto | September 26, 2018 |
| NCT02658968 | Recruiting | Relapsed, Diffuse Large B-cell Lymphoma;Refractory Diffuse Large B-Cell Lymphoma | Nordic Nanovector | April 10, 2017 |
| NCT02657447 | Recruiting | Non-Hodgkin Lymphoma | Nordic Nanovector | May 3, 2018 |
| NCT01484093 | Active, not recruiting | Mantle Cell Lymphoma | Memorial Sloan Kettering Cancer Center | September 11, 2018 |
| NCT00968760 | Active, not recruiting | Lymphoma;B-cell Lymphoma | M.D. Anderson Cancer Center | January 10, 2018 |
| NCT00889798 | Active, not recruiting | Non-Hodgkin's Lymphoma (NHL);Chronic Lymphocytic Leukemia (CLL);Multiple Myeloma (MM); | iOMEDICO AG | August 10, 2018 |
| NCT02629809 | Recruiting | Chronic Lymphocytic Leukemia;Immunoglobulin Heavy Chain Locus Variable Region Mutation;Small Lymphocytic Lymphoma; | M.D. Anderson Cancer Center | October 31, 2018 |
| NCT01742988 | Active, not recruiting | Multiple Myeloma;Lymphoma | Curis, Inc. | February 5, 2018 |
| NCT03610217 | Not yet recruiting | Scleroderma, Systemic;Sclerosis, Systemic | University of West London | August 6, 2018 |
| NCT00863460 | Active, not recruiting | Primary Central Nervous System Lymphoma | Institut Curie | March 9, 2018 |
| NCT02294487 | Active, not recruiting | Multiple Myeloma;Myeloma, Multiple;Myeloma-Multiple; | Michael A. Thompson, MD, PhD | July 2, 2018 |
| NCT01946880 | Active, not recruiting | Systemic Lupus Erythematosus;SLE | National Institute of Allergy and Infectious Diseases (NIAID) | May 16, 2018 |
| NCT03269669 | Recruiting | Grade 1 Follicular Lymphoma;Grade 2 Follicular Lymphoma;Grade 3a Follicular Lymphoma;Recurrent Follicular Lymphoma;Refractory Follicular Lymphoma; | National Cancer Institute (NCI) | November 26, 2018 |
| NCT02171104 | Recruiting | Mucopolysaccharidosis Disorders;Hurler Syndrome;Hunter Syndrome;Maroteaux Lamy Syndrome;Sly Syndrome;Alpha-Mannosidosis;Fucosidosis;Aspartylglucosaminuria;Glycoprotein Metabolic Disorders;Sphingolipidoses;Recessive Leukodystrophies;Globoid Cell Leukodystrophy;Metachromatic Leukodystrophy;Niemann-Pick B;Niemann-Pick C Subtype 2;Sphingomyelin Deficiency; Peroxisomal Disorders;Adrenoleukodystrophy With Cerebral Involvement; Zellweger Syndrome; Neonatal Adrenoleukodystrophy; Infantile Refsum Disease; Acyl-CoA Oxidase Deficiency; D-Bifunctional Enzyme Deficiency; Multifunctional Enzyme Deficiency; Alpha-methylacyl-CoA Racmase Deficiency; Mitochondrial Neurogastrointestingal Encephalopathy;Severe Osteopetrosis; Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation); Inherited Metabolic Disorders; | Masonic Cancer Center, University of Minnesota | September 26, 2018 |
| NCT03444805 | Not yet recruiting | Autoimmune Diseases | European Group for Blood and Marrow Transplantation | May 1, 2018 |
Table 2. Approved Drugs of Rituximab**
| INN (trade name) | Therapeutic area | Dose | Strength | Route | Company | Marketing start | Market |
| Rituxan | Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; Rheumatoid Arthritis; Granulomatosis with Polyangiitis; Moderate to severe Pemphigus Vulgaris; | Concentrate for solution for infusion | 10mg/ml | Intravenous infusion | GENENTECH | November 26, 1997 |
|
| Truxima | Non-Hodgkin’s Lymphoma (NHL) | Concentrate for solution for infusion | 10mg/ml | Intravenous infusion | CELLTRION INC | November 28, 2018 |
|
| Rituxan Hycela | Follicular Lymphoma; Diffuse Large B-cell Lymphoma; Chronic Lymphocytic Leukemia | Concentrate for solution for infusion | 120mg/2000 Units per ml | Intravenous infusion | GENENTECH INC | June 22, 2017 |
|
| MabThera |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell; |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Roche Registration GmbH |
June 02, 1998 |
|
| Rixathon |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell; Wegener Granulomatosis; Microscopic Polyangiitis |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Sandoz GmbH | June 15, 2017 |
|
| Truxima |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis; |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Celltrion Healthcare Hungary Kft. | February 17, 2017 |
|
| Riximyo |
Leukemia, Lymphocytic, Chronic, B-Cell; Wegener Granulomatosis; Microscopic Polyangiitis |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Sandoz GmbH | June 15, 2017 |
|
| Ritemvia |
Lymphoma, Non-Hodgkin; Microscopic Polyangiitis; Wegener Granulomatosis |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Celltrion Healthcare Hungary Kft. | 13 July, 2017 |
|
| Rituzena (previously Tuxella) |
Lymphoma, Non-Hodgkin; Microscopic Polyangiitis; Leukemia, Lymphocytic, Chronic, B-Cell; Wegener Granulomatosis; |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Celltrion Healthcare Hungary Kft. | 13 July, 2017 |
|
| Blitzima |
Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell |
Concentrate for solution for infusion | 100mg / vial | Intravenous infusion | Celltrion Healthcare Hungary Kft. | 13 July, 2017 |
|
| Rituxan | CD20 positive B cell non-Hodgkin's lymphoma; Wegenera granulomatosis; Chronic idiopathic thrombocytopenic purpura; | Solution for Infusion | 10mg/ml | Intramuscular injection |
All Chemical Industry Co., Ltd. Publisher / Chugai Pharmaceutical Co., Ltd. |
June 20, 2001 |
|
| Rituxan | CD20 positive B cell non-Hodgkin's lymphoma; Wegenera granulomatosis; Chronic idiopathic thrombocytopenic purpura; | Solution for Infusion | 10ml/vial | Intravenous infusion |
All Chemical Industry Co., Ltd. Publisher / Chugai Pharmaceutical Co., Ltd. |
June 20, 2001 |
|
| Rituximab BS | CD20 positive B cell non-Hodgkin's lymphoma; Wegenera granulomatosis; Chronic idiopathic thrombocytopenic purpura; | Solution for Infusion | 10ml/vial | Intravenous infusion |
Kyowa Hakko Kirin Co., Ltd. Manufacture / Sales / Sand Corporation |
September 27, 2017 |
|
| RITUXAN | Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; Rheumatoid Arthritis; Granulomatosis with Polyangiitis and Microscopic Polyangiitis; | Solution for Injection | 10 mg / ml | Intravenous infusion | Hoffmann-La Roche Ltd. | October 13, 2016 |
|
| RITUXAN SC | Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; | Solution for Injection | 120mg /ml | Subcutaneous Injection | Hoffmann-La Roche Ltd. | May 31, 2018 |
|
| RITUXAN SC | Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukemia; | Solution for Injection | 120mg /ml | Subcutaneous Injection | Hoffmann-La Roche Ltd. | March 21, 2018 |
|
| MabThera | Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukaemia; Rheumatoid Arthritis; Granulomatosis with polyangiitis; Microscopic polyangiitis; | Concentrate for solution for infusion. | 100 mg/10 mL | Intravenous infusion | Roche Products Pty Ltd. | February 9, 2017 |
|
|
Riximyo |
Non-Hodgkin’s Lymphoma; Chronic Lymphocytic Leukaemia; Rheumatoid Arthritis; | Concentrate for solution for infusion. | 100 mg/ 10 mL | Intravenous infusion | Sandoz Pty Ltd | August 23, 2018 |
|
| MabThera | Rheumatoid Arthritis | Concentrate for solution for infusion. | 100 mg/ 10 mL | Intravenous infusion | Roche Products Pty Ltd. | August 27, 2015 |
|
What We Provide
Therapeutic Antibody
Reference
* The table was excerpted from the following website
https://clinicaltrials.gov/ct2/results?cond=&term=Rituximab
**Information presented in the table were collected from the following website:
https://www.kegg.jp/medicus-bin/search_drug?display=med&thumbnail=&method=¤t_submit=&search_keyword=Rituximab&submit
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103705
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.